An	O
isotype-specific	O
activator	O
of	O
major	B-DNA
histocompatibility	I-DNA
complex	I-DNA
(	I-DNA
MHC	I-DNA
)	I-DNA
class	I-DNA
II	I-DNA
genes	I-DNA
that	O
is	O
independent	O
of	O
class	B-protein
II	I-protein
transactivator	I-protein
.	O

Patients	O
with	O
one	O
type	O
of	O
major	B-protein
histocompatibility	I-protein
complex	I-protein
class	I-protein
II	I-protein
combined	O
immunodeficiency	O
have	O
mutations	O
in	O
a	O
gene	O
termed	O
class	B-protein
II	I-protein
transactivator	I-protein
(	O
CIITA	B-protein
)	O
,	O
which	O
coordinately	O
controls	O
the	O
transcription	O
of	O
the	O
three	O
major	O
human	B-DNA
class	I-DNA
II	I-DNA
genes	I-DNA
,	O
HLA-DR	B-DNA
,	I-DNA
-DQ	I-DNA
,	I-DNA
and	I-DNA
-DP	I-DNA
.	O

However	O
,	O
the	O
experimentally	O
derived	O
B-lymphoblastoid	B-cell_line
cell	I-cell_line
line	I-cell_line
,	O
clone	B-cell_line
13	I-cell_line
,	O
expresses	O
high	O
levels	O
of	O
HLADQ	B-protein
in	O
the	O
absence	O
of	O
HLA-DR	B-DNA
and	O
HLA-DP	B-DNA
,	O
despite	O
its	O
mapping	O
by	O
complementation	O
analysis	O
to	O
this	O
group	O
.	O

It	O
was	O
possible	O
that	O
one	O
of	O
the	O
clone	B-DNA
13	I-DNA
CIITA	I-DNA
alleles	I-DNA
bore	O
a	O
mutation	O
that	O
allowed	O
HLA-DQ	B-DNA
,	O
but	O
not	O
HLA-DR	O
or	O
-DP	O
transcription	O
.	O

Alternatively	O
,	O
another	O
factor	O
,	O
distinct	O
from	O
CIITA	B-protein
,	O
might	O
control	O
HLA-DQ	B-DNA
expression	O
.	O

We	O
report	O
here	O
that	O
ectopic	O
expression	O
of	O
CIITA	B-DNA
cDNAs	I-DNA
derived	O
by	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
from	O
clone	B-cell_line
13	I-cell_line
do	O
not	O
restore	O
expression	O
of	O
HLA-DQ	B-DNA
in	O
another	O
CIITA-deficient	B-cell_line
cell	I-cell_line
line	I-cell_line
,	O
RJ2.2.5	B-cell_line
.	O

In	O
addition	O
,	O
no	O
CIITA	B-protein
protein	O
is	O
detectable	O
in	O
clone	B-cell_line
13	I-cell_line
nuclear	O
extracts	O
.	O

In	O
contrast	O
,	O
somatic	O
cell	O
fusion	O
between	O
clone	B-cell_line
13	I-cell_line
and	O
RJ2.2.5	B-cell_line
restored	O
expression	O
of	O
the	O
HLA-DQ	B-DNA
haplotype	O
encoded	O
by	O
the	O
RJ2.2.5	B-DNA
DQB	I-DNA
gene	I-DNA
.	O

Taken	O
together	O
,	O
these	O
data	O
demonstrate	O
the	O
existence	O
of	O
an	O
HLA-DQ	B-protein
isotype-specific	I-protein
trans-acting	I-protein
factor	I-protein
,	O
which	O
functions	O
independently	O
of	O
CIITA	B-protein
.	O

An	NULL
Isotype-specific	NULL
Activator	NULL
of	NULL
Major	NULL
Histocom	NULL
patibility	NULL
Complex	NULL
(	NULL
MHC	NULL
)	NULL
Class	NULL
II	NULL
Genes	NULL
That	NULL
Is	NULL
Independent	NULL
of	NULL
Class	NULL
II	NULL
Transactivator	NULL
By	NULL
John	NULL
Douhan	NULL
III	NULL
,	NULL
**	NULL
Rebecca	NULL
Lieberson	NULL
,	NULL
*	NULL
Joan	NULL
H.M.	NULL
Knoll	NULL
,	NULL
$	NULL
Hong	NULL
Zhou	NULL
,	NULL
*	NULL
and	NULL
Laurie	NULL
H.	NULL
Glimcher*	NULL
$	NULL
!	NULL

From	NULL
the	NULL
*	NULL
Harvard	NULL
School	NULL
of	NULL
Public	NULL
Health	NULL
,	NULL
Department	NULL
of	NULL
C	NULL
ancer	NULL
Biology	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
;	NULL
*Program	NULL
in	NULL
Immunology	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
;	NULL
$	NULL
Division	NULL
of	NULL
Genetics	NULL
Children	NULL
's	NULL
Hospital	NULL
and	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Beth	NULL
Ismel	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
;	NULL
and	NULL
the	NULL
HDepaznmmt	NULL
of	NULL
Medicane	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
Sum	NULL
m	NULL
ary	NULL
Patients	NULL
with	NULL
one	NULL
type	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
combined	NULL
immunodeficiency	NULL
have	NULL
mutations	NULL
in	NULL
a	NULL
gene	NULL
termed	NULL
class	NULL
II	NULL
transactivator	NULL
(	NULL
CHT	NULL
A	NULL
)	NULL
,	NULL
which	NULL
coordinately	NULL
controls	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
three	NULL
major	NULL
human	NULL
class	NULL
II	NULL
genes	NULL
,	NULL
HLA-DR	NULL
,	NULL
-DQ	NULL
,	NULL
and	NULL
-DP	NULL
.	NULL

However	NULL
,	NULL
the	NULL
experimentally	NULL
derived	NULL
B-lymphoblastoid	NULL
cell	NULL
line	NULL
,	NULL
clone	NULL
13	NULL
,	NULL
expresses	NULL
high	NULL
levels	NULL
of	NULL
HLA-DQ	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
HLA-DR	NULL
and	NULL
HLA-DP	NULL
,	NULL
despite	NULL
its	NULL
mapping	NULL
by	NULL
complementation	NULL
analysis	NULL
to	NULL
this	NULL
group	NULL
.	NULL

It	NULL
was	NULL
possible	NULL
that	NULL
one	NULL
of	NULL
the	NULL
clone	NULL
13	NULL
CIT	NULL
A	NULL
alleles	NULL
bore	NULL
a	NULL
mutation	NULL
that	NULL
allowed	NULL
HLA-DQ	NULL
,	NULL
but	NULL
not	NULL
HLA-DR	NULL
or	NULL
-DP	NULL
transcription	NULL
.	NULL

Alternatively	NULL
,	NULL
another	NULL
factor	NULL
,	NULL
dis	NULL
tinct	NULL
from	NULL
CIITA	NULL
,	NULL
might	NULL
control	NULL
HLA-DQ	NULL
expression	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
ectopic	NULL
expression	NULL
of	NULL
CIITA	NULL
cDN	NULL
As	NULL
derived	NULL
by	NULL
reverse	NULL
transcriptase	NULL
polymerase	NULL
chain	NULL
reaction	NULL
from	NULL
clone	NULL
13	NULL
do	NULL
not	NULL
restore	NULL
expression	NULL
of	NULL
HLA-DQ	NULL
in	NULL
another	NULL
CHT	NULL
A-deficient	NULL
cell	NULL
line	NULL
,	NULL
R	NULL
J2.2.5	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
no	NULL
CIITA	NULL
protein	NULL
is	NULL
detectable	NULL
in	NULL
clone	NULL
13	NULL
nuclear	NULL
extracts	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
somatic	NULL
cell	NULL
fusion	NULL
between	NULL
clone	NULL
13	NULL
and	NULL
RJ2.2.5	NULL
restored	NULL
expression	NULL
of	NULL
the	NULL
HLA-DQ	NULL
haplotype	NULL
encoded	NULL
by	NULL
the	NULL
RJ2.2.5	NULL
DQB	NULL
gene	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
demonstrate	NULL
the	NULL
existence	NULL
of	NULL
an	NULL
HLA-DQ	NULL
iso-	NULL
type-specific	NULL
truns-acting	NULL
factor	NULL
,	NULL
which	NULL
functions	NULL
independently	NULL
of	NULL
CHIT	NULL
A.	NULL
he	NULL
human	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
encode	NULL
highly	NULL
polymorphic	NULL
cell	NULL
surface	NULL
glycoproteins	NULL
,	NULL
which	NULL
are	NULL
responsible	NULL
for	NULL
presenting	NULL
protein	NULL
antigens	NULL
to	NULL
CD4*	NULL
T	NULL
cells	NULL
and	NULL
thus	NULL
initiating	NULL
immune	NULL
responses	NULL
(	NULL
1	NULL
)	NULL
.	NULL

In	NULL
the	NULL
human	NULL
,	NULL
the	NULL
genes	NULL
for	NULL
three	NULL
isotypes	NULL
(	NULL
HLA-DR	NULL
,	NULL
-DQ	NULL
,	NULL
and	NULL
-DP	NULL
)	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
antigens	NULL
are	NULL
located	NULL
in	NULL
the	NULL
HLA-D	NULL
locus	NULL
on	NULL
chromosome	NULL
6	NULL
.	NULL

Each	NULL
isotype	NULL
is	NULL
expressed	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
as	NULL
an	NULL
Â«	NULL
B	NULL
heterodimer	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
antigens	NULL
is	NULL
tightly	NULL
regulated	NULL
and	NULL
is	NULL
limited	NULL
to	NULL
certain	NULL
cells	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
including	NULL
B	NULL
cells	NULL
,	NULL
macrophages	NULL
,	NULL
den-dritic	NULL
cells	NULL
,	NULL
thymic	NULL
epithelium	NULL
,	NULL
and	NULL
activated	NULL
T	NULL
cells	NULL
Furthermore	NULL
,	NULL
surface	NULL
levels	NULL
of	NULL
class	NULL
II	NULL
antigens	NULL
can	NULL
be	NULL
both	NULL
up-and	NULL
downregulated	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
physiologic	NULL
stimuli	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
constitutive	NULL
and	NULL
inducible	NULL
expression	NULL
on	NULL
cells	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
,	NULL
class	NULL
II	NULL
antigens	NULL
can	NULL
also	NULL
be	NULL
induced	NULL
on	NULL
otherwise	NULL
class	NULL
II-negative	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
epithelial	NULL
cells	NULL
,	NULL
tumor	NULL
cells	NULL
and	NULL
rheumatoid	NULL
synovium	NULL
,	NULL
by	NULL
exposure	NULL
to	NULL
cyto-kines	NULL
such	NULL
as	NULL
IFN-y	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
general	NULL
,	NULL
the	NULL
class	NULL
II	NULL
genes	NULL
have	NULL
been	NULL
found	NULL
to	NULL
be	NULL
regulated	NULL
coordinately	NULL
;	NULL
that	NULL
is	NULL
,	NULL
all	NULL
three	NULL
isotypes	NULL
are	NULL
usually	NULL
expressed	NULL
concomitantly	NULL
,	NULL
although	NULL
not	NULL
always	NULL
to	NULL
the	NULL
same	NULL
level	NULL
.	NULL

1885	NULL
B	NULL
lymphocytes	NULL
constitutively	NULL
express	NULL
all	NULL
class	NULL
II	NULL
genes	NULL
,	NULL
and	NULL
macrophages	NULL
,	NULL
when	NULL
stimulated	NULL
with	NULL
IFN-y	NULL
,	NULL
show	NULL
a	NULL
coordinate	NULL
increase	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
all	NULL
class	NULL
II	NULL
genes	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
most	NULL
types	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
combined	NULL
immunodeficiency	NULL
(	NULL
MHC	NULL
class	NULL
II	NULL
CID	NULL
or	NULL
the	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
)	NULL
,	NULL
a	NULL
disease	NULL
characterized	NULL
by	NULL
the	NULL
complete	NULL
lack	NULL
of	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
antigens	NULL
,	NULL
all	NULL
class	NULL
II	NULL
genes	NULL
are	NULL
coordinately	NULL
silenced	NULL
(	NULL
4	NULL
)	NULL
.	NULL

O	NULL
ur	NULL
understanding	NULL
of	NULL
how	NULL
class	NULL
II	NULL
genes	NULL
are	NULL
coordinately	NULL
regulated	NULL
comes	NULL
in	NULL
large	NULL
part	NULL
from	NULL
an	NULL
analysis	NULL
of	NULL
the	NULL
as	NULL
and	NULL
trans	NULL
elements	NULL
necessary	NULL
for	NULL
their	NULL
transcription	NULL
.	NULL

Examination	NULL
of	NULL
the	NULL
5'-flanking	NULL
sequences	NULL
of	NULL
the	NULL
class	NULL
II	NULL
genes	NULL
has	NULL
revealed	NULL
a	NULL
set	NULL
of	NULL
highly	NULL
conserved	NULL
sequence	NULL
motifs	NULL
common	NULL
to	NULL
all	NULL
the	NULL
class	NULL
II	NULL
genes	NULL
within	NULL
and	NULL
between	NULL
species	NULL
.	NULL

These	NULL
conserved	NULL
elements	NULL
,	NULL
designated	NULL
the	NULL
W/S	NULL
,	NULL
X1	NULL
,	NULL
X2	NULL
,	NULL
and	NULL
Y	NULL
boxes	NULL
,	NULL
have	NULL
been	NULL
shown	NULL
by	NULL
mutational	NULL
analysis	NULL
in	NULL
transient	NULL
transfection	NULL
experiments	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
the	NULL
constitutive	NULL
and	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
class	NULL
II	NULL
genes	NULL
(	NULL
2	NULL
,	NULL
5	NULL
)	NULL
.	NULL

A	NULL
number	NULL
of	NULL
proteins	NULL
that	NULL
either	NULL
bind	NULL
directly	NULL
to	NULL
these	NULL
as	NULL
elements	NULL
or	NULL
are	NULL
necessary	NULL
for	NULL
their	NULL
activity	NULL
have	NULL
been	NULL
iden-tified	NULL
,	NULL
both	NULL
through	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

Â©	NULL
The	NULL
R	NULL
ockefeller	NULL
University	NULL
Press	NULL
Â»	NULL
0022-1007/97/06/	NULL
1885/11	NULL
$	NULL
2.00	NULL
Volume	NULL
185	NULL
,	NULL
Number	NULL
11	NULL
,	NULL
June	NULL
2	NULL
,	NULL
1997	NULL
1885-1895	NULL
(	NULL
EMSA	NULL
)	NULL
!	NULL

followed	NULL
by	NULL
protein	NULL
purification	NULL
or	NULL
,	NULL
more	NULL
recently	NULL
,	NULL
by	NULL
complementation/	NULL
expression	NULL
cloning	NULL
.	NULL

The	NULL
latter	NULL
process	NULL
has	NULL
taken	NULL
advantage	NULL
of	NULL
the	NULL
existence	NULL
of	NULL
both	NULL
MHC	NULL
class	NULL
II	NULL
CID	NULL
patient-	NULL
and	NULL
experimentally	NULL
derived	NULL
mutant	NULL
cell	NULL
lines	NULL
that	NULL
do	NULL
not	NULL
express	NULL
class	NULL
II	NULL
genes	NULL
but	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
do	NULL
so	NULL
upon	NULL
somatic	NULL
cell	NULL
fusion	NULL
with	NULL
a	NULL
class	NULL
II-pos	NULL
itive	NULL
cell	NULL
line	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Somatic	NULL
cell	NULL
fusion	NULL
between	NULL
the	NULL
mutant	NULL
cell	NULL
lines	NULL
has	NULL
revealed	NULL
at	NULL
least	NULL
five	NULL
distinct	NULL
complementation	NULL
groups	NULL
(	NULL
I-V	NULL
)	NULL
and	NULL
,	NULL
accordingly	NULL
,	NULL
the	NULL
existence	NULL
of	NULL
at	NULL
least	NULL
five	NULL
genes	NULL
critical	NULL
for	NULL
class	NULL
II	NULL
expression	NULL
(	NULL
7-11	NULL
)	NULL
.	NULL

Two	NULL
of	NULL
these	NULL
genes	NULL
,	NULL
CHIT	NULL
A	NULL
(	NULL
class	NULL
II	NULL
transactivator	NULL
)	NULL
and	NULL
RFX5	NULL
,	NULL
have	NULL
been	NULL
isolated	NULL
by	NULL
expression	NULL
cloning	NULL
from	NULL
a	NULL
wild-type	NULL
cDNA	NULL
library	NULL
using	NULL
cell	NULL
lines	NULL
from	NULL
MHC	NULL
class	NULL
II	NULL
CID	NULL
complementation	NULL
groups	NULL
II	NULL
and	NULL
IV	NULL
,	NULL
respectively	NULL
,	NULL
as	NULL
recipients	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
a	NULL
second	NULL
nomenclature	NULL
for	NULL
these	NULL
groups	NULL
is	NULL
also	NULL
used	NULL
:	NULL
groups	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
(	NULL
12	NULL
)	NULL
correspond	NULL
to	NULL
groups	NULL
II	NULL
,	NULL
I	NULL
,	NULL
and	NULL
IV	NULL
,	NULL
respectively	NULL
.	NULL

Introduction	NULL
of	NULL
a	NULL
wild-type	NULL
cDNA	NULL
encoding	NULL
either	NULL
the	NULL
CHT	NULL
A	NULL
or	NULL
RFX5	NULL
protein	NULL
into	NULL
cell	NULL
lines	NULL
of	NULL
the	NULL
appropriate	NULL
complementation	NULL
group	NULL
resulted	NULL
in	NULL
a	NULL
coordinate	NULL
reexpression	NULL
of	NULL
all	NULL
class	NULL
II	NULL
genes	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

We	NULL
have	NULL
studied	NULL
MHC	NULL
class	NULL
II	NULL
expression	NULL
in	NULL
clone	NULL
13	NULL
,	NULL
a	NULL
B-lymphoblastoid	NULL
cell	NULL
line	NULL
(	NULL
B-LCL	NULL
)	NULL
derived	NULL
from	NULL
the	NULL
class	NULL
II-positive	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
Jijoye	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Unlike	NULL
the	NULL
other	NULL
CHIT	NULL
A-deficient	NULL
cell	NULL
lines	NULL
in	NULL
complementation	NULL
group	NULL
II	NULL
,	NULL
clone	NULL
13	NULL
shows	NULL
a	NULL
noncoordinate	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
antigens	NULL
:	NULL
HLA-DQ	NULL
is	NULL
expressed	NULL
but	NULL
HLA-DR	NULL
and	NULL
-DP	NULL
are	NULL
not	NULL
.	NULL

Transfection	NULL
of	NULL
wild-type	NULL
CHT	NULL
A	NULL
into	NULL
clone	NULL
13	NULL
causes	NULL
the	NULL
reexpression	NULL
of	NULL
both	NULL
HLA-DR	NULL
and	NULL
-DP	NULL
,	NULL
and	NULL
an	NULL
increase	NULL
in	NULL
levels	NULL
of	NULL
HLA-DQ	NULL
,	NULL
thus	NULL
confirming	NULL
that	NULL
CHIT	NULL
A	NULL
is	NULL
indeed	NULL
defective	NULL
in	NULL
clone	NULL
13	NULL
as	NULL
suggested	NULL
by	NULL
the	NULL
complementation	NULL
analyses	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
the	NULL
HLA-DQB	NULL
,	NULL
but	NULL
not	NULL
the	NULL
DR	NULL
A	NULL
promoter	NULL
,	NULL
was	NULL
active	NULL
in	NULL
clone	NULL
13	NULL
cells	NULL
,	NULL
a	NULL
function	NULL
that	NULL
was	NULL
mapped	NULL
by	NULL
DQ/DR	NULL
chimeric	NULL
constructs	NULL
to	NULL
the	NULL
DQB	NULL
X2	NULL
box	NULL
(	NULL
17	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
whether	NULL
or	NULL
not	NULL
the	NULL
expression	NULL
of	NULL
HLA-DQ	NULL
in	NULL
clone	NULL
13	NULL
is	NULL
dependent	NULL
upon	NULL
a	NULL
potentially	NULL
isotype-specific	NULL
allele	NULL
of	NULL
CIITA	NULL
whose	NULL
mutation	NULL
affects	NULL
HLA-DR	NULL
and	NULL
-DP	NULL
,	NULL
but	NULL
not	NULL
-DQ	NULL
expres	NULL
sion	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
HLA-DQ	NULL
in	NULL
clone	NULL
13	NULL
is	NULL
due	NULL
to	NULL
an	NULL
isotype-specific	NULL
trans-acting	NULL
factor	NULL
that	NULL
acts	NULL
independently	NULL
of	NULL
CHIT	NULL
A	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
Lines	NULL
and	NULL
T	NULL
-	NULL
The	NULL
B-LCL	NULL
clone	NULL
13	NULL
(	NULL
15	NULL
)	NULL
,	NULL
R	NULL
J2.2.5	NULL
(	NULL
18	NULL
)	NULL
,	NULL
and	NULL
Raji	NULL
(	NULL
ATCC	NULL
CCL	NULL
86	NULL
;	NULL
American	NULL
Type	NULL
Culture	NULL
Collec-tion	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
made	NULL
10	NULL
%	NULL
in	NULL
heat-inactivated	NULL
FCS	NULL
supplemented	NULL
with	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.2	NULL
,	NULL
100	NULL
U/	NULL
ml	NULL
penicillin	NULL
,	NULL
100	NULL
g/	NULL
ml	NULL
streptomycin	NULL
,	NULL
50	NULL
mM	NULL
2-mercaptoethanol	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
1-glutamine	NULL
(	NULL
complete	NULL
me-dium	NULL
)	NULL
.	NULL

For	NULL
transfections	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
once	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
resuspended	NULL
to	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
X	NULL
10	NULL
``	NULL
celly	NULL
ml	NULL
in	NULL
PBS	NULL
,	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.2	NULL
.	NULL

10	NULL
``	NULL
cells	NULL
in	NULL
0.5	NULL
ml	NULL
were	NULL
mixed	NULL
with	NULL
10	NULL
wg	NULL
DNA	NULL
,	NULL
transferred	NULL
to	NULL
an	NULL
0.4-cm	NULL
electroporation	NULL
cuvette	NULL
and	NULL
!	NULL

A	NULL
bbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
B-LCL	NULL
,	NULL
B-lymphoblastoid	NULL
cell	NULL
line	NULL
;	NULL
CID	NULL
,	NULL
combined	NULL
immunodeficiency	NULL
;	NULL
CHIT	NULL
A	NULL
,	NULL
class	NULL
II	NULL
transactivator	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

1886	NULL
electroporated	NULL
at	NULL
250	NULL
V	NULL
,	NULL
960	NULL
F	NULL
using	NULL
a	NULL
Bio-Rad	NULL
GenePulser	NULL
II	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Melville	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

After	NULL
electroporation	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
complete	NULL
medium	NULL
and	NULL
plated	NULL
at	NULL
a	NULL
density	NULL
of	NULL
2-4	NULL
X	NULL
10Â°	NULL
cells/	NULL
ml	NULL
.	NULL

Drug	NULL
selection	NULL
was	NULL
initiated	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
either	NULL
hygromycin	NULL
B	NULL
(	NULL
450	NULL
g/	NULL
ml	NULL
)	NULL
or	NULL
neomycin	NULL
(	NULL
750	NULL
pg/ml	NULL
)	NULL
as	NULL
appropriate	NULL
.	NULL

Cells	NULL
were	NULL
analyzed	NULL
for	NULL
expression	NULL
of	NULL
surface	NULL
antigens	NULL
14	NULL
d	NULL
after	NULL
transfection	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

PCR	NULL
.	NULL

For	NULL
RT-PCR	NULL
,	NULL
2	NULL
jg	NULL
of	NULL
clone	NULL
13	NULL
RNA	NULL
was	NULL
reverse	NULL
transcribed	NULL
using	NULL
SuperScript	NULL
(	NULL
GIBCO	NULL
BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
.	NULL

A	NULL
portion	NULL
of	NULL
this	NULL
cDNA	NULL
was	NULL
used	NULL
in	NULL
PCR	NULL
reactions	NULL
with	NULL
pairs	NULL
of	NULL
CIT	NULL
A-spe-cific	NULL
primers	NULL
(	NULL
see	NULL
below	NULL
)	NULL
to	NULL
generate	NULL
the	NULL
clone	NULL
13	NULL
cDNA	NULL
frag-ments	NULL
.	NULL

The	NULL
6.6-kb	NULL
PCR	NULL
fragment	NULL
derived	NULL
from	NULL
either	NULL
clone	NULL
13	NULL
or	NULL
Raji	NULL
genomic	NULL
DNA	NULL
was	NULL
prepared	NULL
using	NULL
primers	NULL
F246	NULL
and	NULL
R	NULL
248	NULL
and	NULL
the	NULL
Expand	NULL
Long	NULL
Template	NULL
PCR	NULL
System	NULL
(	NULL
Boehringer-Mannhein	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
.	NULL

All	NULL
PCR	NULL
fragments	NULL
were	NULL
subcloned	NULL
into	NULL
pCR	NULL
II	NULL
(	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
subsequent	NULL
manipulation	NULL
and	NULL
sequence	NULL
analysis	NULL
.	NULL

The	NULL
following	NULL
oligonucleotide	NULL
primers	NULL
were	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

Primers	NULL
preceded	NULL
by	NULL
F	NULL
are	NULL
complementary	NULL
to	NULL
the	NULL
noncoding	NULL
strand	NULL
of	NULL
the	NULL
CIITA	NULL
cDNA	NULL
,	NULL
whereas	NULL
those	NULL
primers	NULL
preceded	NULL
by	NULL
an	NULL
R	NULL
are	NULL
complementary	NULL
to	NULL
the	NULL
CIITA	NULL
coding	NULL
strand	NULL
.	NULL

The	NULL
position	NULL
number	NULL
given	NULL
in	NULL
parentheses	NULL
indicate	NULL
the	NULL
nucleotide	NULL
position	NULL
of	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
primer	NULL
.	NULL

Nucleotide	NULL
numbering	NULL
is	NULL
based	NULL
on	NULL
Steimle	NULL
et	NULL
al	NULL
.	NULL

(	NULL
13	NULL
)	NULL
F204	NULL
,	NULL
5-GGAAGCTGAGGGCACGAGGAG-3	NULL
'	NULL
(	NULL
nt	NULL
248	NULL
)	NULL
;	NULL
R207	NULL
,	NULL
5-CCCCAGCCCAATAGCTCTTG-3	NULL
'	NULL
(	NULL
nt	NULL
1,409	NULL
)	NULL
;	NULL
F206	NULL
,	NULL
5-CTCCAACAAGCTTCCAAAAT-3	NULL
``	NULL
(	NULL
nt	NULL
1,096	NULL
)	NULL
;	NULL
R214	NULL
,	NULL
5	NULL
``	NULL
-CGC-ATCCAGGTCCAGATGCT-3	NULL
'	NULL
(	NULL
nt	NULL
3,094	NULL
)	NULL
;	NULL
F215	NULL
,	NULL
5-GATGGC-CAAAGGCTTAGTCCAAC-3	NULL
'	NULL
(	NULL
nt	NULL
2,182	NULL
)	NULL
;	NULL
R201	NULL
,	NULL
5-CCTCTC-AGCGCCCCATTAGTGTC-3	NULL
'	NULL
(	NULL
nt	NULL
4,447	NULL
)	NULL
;	NULL
R251	NULL
,	NULL
5-CAT-CACCCGGAGGGACACCAT-3	NULL
``	NULL
(	NULL
nt	NULL
3,346	NULL
)	NULL
;	NULL
F212	NULL
,	NULL
5-GTCCCT-GAAGGATGTGGAAGAC-3	NULL
'	NULL
(	NULL
nt	NULL
2,884	NULL
)	NULL
;	NULL
F246	NULL
,	NULL
5-TTCCCC-AAACTGGTGCGGATCCTCACGGCC-3	NULL
``	NULL
'	NULL
(	NULL
nt	NULL
3,032	NULL
)	NULL
;	NULL
R	NULL
248	NULL
,	NULL
5-TTGTACTGGACGTCCATCACCCGGAG	NULL
GGAC-3	NULL
'	NULL
(	NULL
nt	NULL
3,360	NULL
)	NULL
.	NULL

Plasmids	NULL
.	NULL

-	NULL
The	NULL
expression	NULL
plasmids	NULL
pCMV	NULL
.	NULL

CHT	NULL
A	NULL
,	NULL
which	NULL
directs	NULL
the	NULL
expression	NULL
of	NULL
wild-type	NULL
CHIT	NULL
A	NULL
,	NULL
and	NULL
pCMV	NULL
.	NULL

KÂ®	NULL
,	NULL
which	NULL
directs	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
murine	NULL
MHC	NULL
class	NULL
I	NULL
antigen	NULL
KP	NULL
,	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Both	NULL
plasmids	NULL
are	NULL
maintained	NULL
episomally	NULL
and	NULL
confer	NULL
resistance	NULL
to	NULL
hygromycin	NULL
in	NULL
trans	NULL
fected	NULL
cells	NULL
.	NULL

The	NULL
plasmid	NULL
pR	NULL
EPI	NULL
.	NULL

D4	NULL
was	NULL
constructed	NULL
by	NULL
excising	NULL
a	NULL
1,058-bp	NULL
EcoRI	NULL
fragment	NULL
bearing	NULL
the	NULL
DC	NULL
cDNA	NULL
from	NULL
pDÂ°V	NULL
(	NULL
the	NULL
gift	NULL
of	NULL
D.	NULL
Singer	NULL
,	NULL
NCI	NULL
,	NULL
NIH	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

After	NULL
treatment	NULL
with	NULL
Klenow	NULL
and	NULL
ligation	NULL
of	NULL
Sall	NULL
linkers	NULL
,	NULL
the	NULL
DC	NULL
cDNA	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
Xhol	NULL
site	NULL
of	NULL
pR	NULL
EP9	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

This	NULL
plasmid	NULL
is	NULL
also	NULL
maintained	NULL
episomally	NULL
but	NULL
confers	NULL
resistance	NULL
to	NULL
neomycin	NULL
.	NULL

The	NULL
clone	NULL
13-derived	NULL
PCR	NULL
fragments	NULL
spanning	NULL
the	NULL
CIITA	NULL
cDNA	NULL
were	NULL
subcloned	NULL
into	NULL
pCRII	NULL
(	NULL
Invitrogen	NULL
)	NULL
for	NULL
sequence	NULL
analysis	NULL
and	NULL
further	NULL
subcloning	NULL
.	NULL

Chimeric	NULL
CIITA	NULL
cDNA	NULL
molecules	NULL
were	NULL
constructed	NULL
from	NULL
the	NULL
subcloned	NULL
clone	NULL
13	NULL
fragments	NULL
and	NULL
from	NULL
wild-type	NULL
CIITA	NULL
by	NULL
taking	NULL
advantage	NULL
of	NULL
the	NULL
unique	NULL
NotI	NULL
,	NULL
BsaWI	NULL
,	NULL
and	NULL
BamHI	NULL
restriction	NULL
sites	NULL
present	NULL
in	NULL
the	NULL
CHT	NULL
A	NULL
cDNA	NULL
and	NULL
inserted	NULL
into	NULL
pCEP4	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

These	NULL
expression	NULL
constructs	NULL
are	NULL
designated	NULL
pCMV.CIITAA4	NULL
,	NULL
pCMV.CIHITAA9Q3	NULL
,	NULL
and	NULL
pCMV.CIITAA147	NULL
and	NULL
encode	NULL
mutant	NULL
forms	NULL
of	NULL
CHIT	NULL
A	NULL
detected	NULL
in	NULL
clone	NULL
13	NULL
(	NULL
as	NULL
described	NULL
in	NULL
R	NULL
esults	NULL
)	NULL
bearing	NULL
the	NULL
4-	NULL
,	NULL
93-	NULL
,	NULL
or	NULL
147-bp	NULL
deletions	NULL
,	NULL
respectively	NULL
.	NULL

W	NULL
estem	NULL
Blot	NULL
Analysis	NULL
of	NULL
CIITA	NULL
.	NULL

-	NULL
Nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
from	NULL
R	NULL
aji	NULL
,	NULL
clone	NULL
13	NULL
,	NULL
or	NULL
R	NULL
J2.2.5	NULL
cells	NULL
transfected	NULL
with	NULL
either	NULL
pCMV.KÂ®	NULL
,	NULL
pCMV.CHITA	NULL
,	NULL
pCMV.CHTAA4	NULL
,	NULL
pCMV.CIHTAA93	NULL
,	NULL
or	NULL
pCMV.CIHITAA147	NULL
(	NULL
19	NULL
)	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

30	NULL
wg	NULL
protein	NULL
was	NULL
run	NULL
on	NULL
a	NULL
6	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
trans	NULL
An	NULL
HLA-DQ	NULL
specific	NULL
T	NULL
ransactivator	NULL
ferred	NULL
to	NULL
nitrocellulose	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
probed	NULL
with	NULL
a	NULL
cocktail	NULL
of	NULL
murine	NULL
anti-CIIT	NULL
A	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
all	NULL
IgG1	NULL
)	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Antibody	NULL
probed	NULL
filters	NULL
were	NULL
reacted	NULL
with	NULL
horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
anti-mouse	NULL
IgG1	NULL
(	NULL
Southern	NULL
Biotechnology	NULL
As-sociates	NULL
,	NULL
Birmingham	NULL
,	NULL
AL	NULL
)	NULL
and	NULL
were	NULL
developed	NULL
using	NULL
a	NULL
Blotting	NULL
Detection	NULL
Kit	NULL
(	NULL
Amersham	NULL
Corp.	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Cytogenetic	NULL
Analysis	NULL
.	NULL

Clone	NULL
13	NULL
was	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
1	NULL
%	NULL
1-glutamine	NULL
.	NULL

Metaphase	NULL
chromosomes	NULL
were	NULL
prepared	NULL
by	NULL
standard	NULL
methods	NULL
and	NULL
chromosome	NULL
preparations	NULL
were	NULL
GTG-banded	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Fluorescence	NULL
in	NULL
situ	NULL
hybridization	NULL
with	NULL
a	NULL
digoxigenin-dUTP-labeled	NULL
whole	NULL
chromosome	NULL
paint	NULL
for	NULL
chromosome	NULL
16	NULL
(	NULL
Oncor	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
was	NULL
performed	NULL
.	NULL

The	NULL
whole	NULL
chromosome	NULL
paint	NULL
was	NULL
detected	NULL
with	NULL
a	NULL
rhodamine-con-jugated	NULL
antibody	NULL
to	NULL
digoxigenin	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Chromosomes	NULL
were	NULL
identified	NULL
by	NULL
counterstaining	NULL
with	NULL
DAPI	NULL
(	NULL
4',6-diaminido-2-phenylindole	NULL
)	NULL
.	NULL

Hybridizations	NULL
were	NULL
viewed	NULL
with	NULL
an	NULL
epifluorescence	NULL
microscope	NULL
equipped	NULL
with	NULL
a	NULL
triple	NULL
band-pass	NULL
filter	NULL
set	NULL
(	NULL
FITC-Texas	NULL
red-DAPI	NULL
;	NULL
ChromaTech	NULL
,	NULL
Brattle-boro	NULL
,	NULL
VT	NULL
)	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
the	NULL
whole	NULL
chromosome	NULL
paint	NULL
.	NULL

A	NULL
standard	NULL
single	NULL
band	NULL
pass	NULL
filter	NULL
(	NULL
Zeiss	NULL
)	NULL
was	NULL
used	NULL
to	NULL
view	NULL
the	NULL
DAPI	NULL
counterstain	NULL
.	NULL

Cells	NULL
were	NULL
scored	NULL
for	NULL
subtle	NULL
rearrangements	NULL
of	NULL
chromosome	NULL
16	NULL
not	NULL
detectable	NULL
by	NULL
routine	NULL
GTG	NULL
banding	NULL
.	NULL

Preparation	NULL
and	NULL
Analysis	NULL
of	NULL
Cell	NULL
Fusions	NULL
.	NULL

-	NULL
For	NULL
the	NULL
preparation	NULL
of	NULL
stable	NULL
fusions	NULL
between	NULL
RJ2.2.5/KÂ®	NULL
and	NULL
clone	NULL
13/D	NULL
%	NULL
,	NULL
10	NULL
``	NULL
cells	NULL
of	NULL
each	NULL
type	NULL
were	NULL
mixed	NULL
in	NULL
a	NULL
50-ml	NULL
centrifuge	NULL
tube	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
serum-free	NULL
medium	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
disaggregated	NULL
by	NULL
three	NULL
passages	NULL
through	NULL
an	NULL
18-gauge	NULL
needle	NULL
and	NULL
were	NULL
washed	NULL
once	NULL
more	NULL
in	NULL
serum-free	NULL
medium	NULL
.	NULL

Cell	NULL
pellets	NULL
were	NULL
gently	NULL
dis	NULL
persed	NULL
and	NULL
warmed	NULL
to	NULL
37Â°C	NULL
.	NULL

Fusion	NULL
was	NULL
initiated	NULL
by	NULL
the	NULL
dropwise	NULL
addition	NULL
of	NULL
1	NULL
ml	NULL
PEG	NULL
1,500	NULL
(	NULL
50	NULL
%	NULL
wt/	NULL
vol	NULL
)	NULL
(	NULL
Boehringer-Mann-heim	NULL
)	NULL
,	NULL
over	NULL
the	NULL
course	NULL
of	NULL
1	NULL
min	NULL
.	NULL

50	NULL
ml	NULL
of	NULL
serum-free	NULL
medium	NULL
was	NULL
then	NULL
added	NULL
slowly	NULL
over	NULL
a	NULL
5-min	NULL
period	NULL
.	NULL

Cells	NULL
were	NULL
rested	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
5	NULL
min	NULL
,	NULL
pelleted	NULL
at	NULL
250	NULL
g	NULL
for	NULL
3	NULL
min	NULL
,	NULL
and	NULL
plated	NULL
in	NULL
50	NULL
ml	NULL
of	NULL
complete	NULL
medium	NULL
.	NULL

Drug	NULL
selection	NULL
in	NULL
hygromycin	NULL
and	NULL
neomycin	NULL
at	NULL
the	NULL
concentrations	NULL
given	NULL
above	NULL
was	NULL
started	NULL
at	NULL
48	NULL
h	NULL
after	NULL
fusion	NULL
.	NULL

For	NULL
flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
the	NULL
fused	NULL
cell	NULL
population	NULL
,	NULL
the	NULL
following	NULL
antibodies	NULL
were	NULL
used	NULL
:	NULL
KÂ®	NULL
expression	NULL
was	NULL
detected	NULL
by	NULL
primary	NULL
staining	NULL
with	NULL
mAb	NULL
Y-3	NULL
(	NULL
ATCC	NULL
HB-176	NULL
)	NULL
followed	NULL
by	NULL
reaction	NULL
with	NULL
PE-sheep	NULL
anti-mouse	NULL
IgG	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

DS	NULL
expression	NULL
was	NULL
detected	NULL
by	NULL
an	NULL
anti-D-FITC	NULL
(	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
DQ2	NULL
was	NULL
detected	NULL
by	NULL
primary	NULL
staining	NULL
with	NULL
an	NULL
anti-DQ2	NULL
human	NULL
monoclonal	NULL
IgM	NULL
(	NULL
Pel-Freez	NULL
Clinical	NULL
Systems	NULL
,	NULL
Brown	NULL
Deer	NULL
,	NULL
WI	NULL
)	NULL
followed	NULL
by	NULL
staining	NULL
with	NULL
a	NULL
biotinylated	NULL
mouse	NULL
anti-human	NULL
IgM	NULL
mAb	NULL
(	NULL
PharMin-gen	NULL
)	NULL
and	NULL
streptavidin-Red	NULL
670	NULL
(	NULL
GIBCO	NULL
BRL	NULL
)	NULL
.	NULL

Appropriate	NULL
isotype	NULL
control	NULL
reagents	NULL
were	NULL
purchased	NULL
from	NULL
PharMingen	NULL
.	NULL

All	NULL
antibody	NULL
incubations	NULL
and	NULL
washes	NULL
were	NULL
performed	NULL
at	NULL
4Â°C	NULL
in	NULL
PBS	NULL
containing	NULL
0.3	NULL
%	NULL
BSA	NULL
and	NULL
0.1	NULL
%	NULL
NaN	NULL
;	NULL
.	NULL

Cells	NULL
were	NULL
fixed	NULL
in	NULL
1	NULL
%	NULL
formaldehyde	NULL
before	NULL
analysis	NULL
on	NULL
a	NULL
FAC	NULL
ScanÂ®	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
that	NULL
had	NULL
been	NULL
calibrated	NULL
with	NULL
Becton	NULL
Dickinson	NULL
Calibrate	NULL
Beads	NULL
.	NULL

Viable	NULL
cells	NULL
were	NULL
selected	NULL
using	NULL
forward	NULL
and	NULL
side	NULL
scatter	NULL
analysis	NULL
.	NULL

For	NULL
RT-PCR	NULL
analysis	NULL
of	NULL
HLA-DQ	NULL
expression	NULL
in	NULL
the	NULL
fusions	NULL
and	NULL
in	NULL
the	NULL
individual	NULL
fusion	NULL
partners	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
(	NULL
23	NULL
)	NULL
.	NULL

After	NULL
DNase	NULL
I	NULL
treatment	NULL
,	NULL
2	NULL
jpg	NULL
of	NULL
RNA	NULL
was	NULL
reverse	NULL
transcribed	NULL
using	NULL
SuperScript	NULL
(	NULL
GIBCO	NULL
BRL	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

A	NULL
portion	NULL
of	NULL
this	NULL
first-strand	NULL
cDNA	NULL
was	NULL
used	NULL
in	NULL
PCR	NULL
reactions	NULL
containing	NULL
either	NULL
DQw2,3,4	NULL
group-specific	NULL
primers	NULL
or	NULL
DQw1	NULL
group-specific	NULL
primers	NULL
(	NULL
23a	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
PCR	NULL
reactions	NULL
were	NULL
then	NULL
digested	NULL
with	NULL
the	NULL
appropriate	NULL
restriction	NULL
endonucleases	NULL
to	NULL
determine	NULL
the	NULL
precise	NULL
allelic	NULL
forms	NULL
of	NULL
DQ	NULL
present	NULL
.	NULL

1887	NULL
Douhan	NULL
et	NULL
al	NULL
.	NULL

Results	NULL
Identification	NULL
of	NULL
Mutant	NULL
CIITA	NULL
mRNA	NULL
in	NULL
Clone	NULL
13	NULL
.	NULL

_	NULL
Stable	NULL
transfection	NULL
of	NULL
clone	NULL
13	NULL
with	NULL
a	NULL
wild-type	NULL
copy	NULL
of	NULL
a	NULL
CHIT	NULL
A	NULL
cDNA	NULL
carried	NULL
in	NULL
an	NULL
episomally	NULL
maintained	NULL
expression	NULL
vector	NULL
,	NULL
pCMV-CIITA	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
restore	NULL
expression	NULL
of	NULL
HLA-DR	NULL
and	NULL
HLA-DP	NULL
and	NULL
increase	NULL
expression	NULL
of	NULL
HLA-DQ	NULL
consistent	NULL
with	NULL
previous	NULL
complementation	NULL
analyses	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
CHT	NULL
A	NULL
is	NULL
at	NULL
least	NULL
partially	NULL
defective	NULL
in	NULL
clone	NULL
13	NULL
.	NULL

However	NULL
,	NULL
it	NULL
was	NULL
not	NULL
possible	NULL
to	NULL
determine	NULL
from	NULL
these	NULL
data	NULL
whether	NULL
HLA-DQ	NULL
expression	NULL
in	NULL
clone	NULL
13	NULL
was	NULL
due	NULL
to	NULL
a	NULL
mutation	NULL
in	NULL
CIHTA	NULL
that	NULL
preserved	NULL
its	NULL
ability	NULL
to	NULL
transactivate	NULL
HLA-DQ	NULL
,	NULL
but	NULL
not	NULL
HLA-DR	NULL
or	NULL
-DP	NULL
,	NULL
or	NULL
was	NULL
secondary	NULL
to	NULL
the	NULL
presence	NULL
in	NULL
clone	NULL
13	NULL
of	NULL
a	NULL
CIT	NULL
A-indepen-dent	NULL
,	NULL
isotype-specific	NULL
trans-acting	NULL
factor	NULL
.	NULL

To	NULL
address	NULL
this	NULL
is	NULL
sue	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
mutation	NULL
(	NULL
s	NULL
)	NULL
present	NULL
in	NULL
the	NULL
clone	NULL
13	NULL
CHT	NULL
A	NULL
genes	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
RNA	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
apparently	NULL
full-length	NULL
CIHTA	NULL
transcripts	NULL
in	NULL
clone	NULL
13	NULL
,	NULL
although	NULL
at	NULL
levels	NULL
somewhat	NULL
lower	NULL
than	NULL
those	NULL
seen	NULL
in	NULL
class	NULL
II-positive	NULL
B-LCL	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
this	NULL
finding	NULL
,	NULL
we	NULL
used	NULL
RT-PCR	NULL
to	NULL
generate	NULL
fragments	NULL
spanning	NULL
the	NULL
entire	NULL
CIHITA	NULL
cDNA	NULL
.	NULL

Initially	NULL
,	NULL
three	NULL
pairs	NULL
of	NULL
oligonucleotide	NULL
primers	NULL
,	NULL
F204/	NULL
R	NULL
207	NULL
,	NULL
F206/	NULL
R	NULL
218	NULL
,	NULL
and	NULL
F215/	NULL
R	NULL
201	NULL
,	NULL
were	NULL
used	NULL
to	NULL
produce	NULL
three	NULL
overlapping	NULL
PCR	NULL
fragments	NULL
from	NULL
which	NULL
a	NULL
full-length	NULL
clone	NULL
13	NULL
CHT	NULL
A	NULL
cDNA	NULL
could	NULL
be	NULL
reconstructed	NULL
.	NULL

These	NULL
PCR	NULL
fragments	NULL
are	NULL
shown	NULL
schematically	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
.	NULL

The	NULL
primer	NULL
pair	NULL
(	NULL
F204	NULL
,	NULL
R	NULL
207	NULL
)	NULL
used	NULL
to	NULL
generate	NULL
the	NULL
5'-most	NULL
fragment	NULL
(	NULL
fragment	NULL
A	NULL
)	NULL
of	NULL
the	NULL
CHT	NULL
A	NULL
cDNA	NULL
yielded	NULL
two	NULL
PCR	NULL
products	NULL
:	NULL
one	NULL
apparently	NULL
full-length	NULL
(	NULL
fragment	NULL
Al	NULL
)	NULL
,	NULL
and	NULL
a	NULL
second	NULL
fragment	NULL
~150	NULL
bp	NULL
shorter	NULL
(	NULL
fragment	NULL
A2	NULL
)	NULL
.	NULL

The	NULL
internal	NULL
fragment	NULL
(	NULL
fragment	NULL
B	NULL
)	NULL
was	NULL
generated	NULL
with	NULL
primers	NULL
(	NULL
F206	NULL
,	NULL
R	NULL
214	NULL
)	NULL
and	NULL
the	NULL
3'-most	NULL
fragment	NULL
(	NULL
fragment	NULL
C	NULL
)	NULL
was	NULL
generated	NULL
with	NULL
primers	NULL
(	NULL
F215	NULL
,	NULL
R	NULL
201	NULL
)	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
fragments	NULL
appeared	NULL
to	NULL
be	NULL
full	NULL
length	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
subcloned	NULL
PCR	NULL
fragments	NULL
revealed	NULL
that	NULL
fragments	NULL
A1	NULL
and	NULL
B	NULL
corresponded	NULL
to	NULL
the	NULL
wild-type	NULL
CIHTA	NULL
sequence	NULL
,	NULL
whereas	NULL
fragment	NULL
A2	NULL
harbored	NULL
a	NULL
147-bp	NULL
in-frame	NULL
deletion	NULL
of	NULL
nucleotides	NULL
597-743	NULL
that	NULL
corresponded	NULL
exactly	NULL
to	NULL
a	NULL
previously	NULL
described	NULL
splice	NULL
variant	NULL
of	NULL
CIHIT	NULL
A	NULL
called	NULL
CHT	NULL
A-	NULL
10	NULL
found	NULL
in	NULL
R	NULL
aji	NULL
cells	NULL
(	NULL
24	NULL
)	NULL
.	NULL

However	NULL
,	NULL
multiple	NULL
independently	NULL
derived	NULL
isolates	NULL
of	NULL
fragment	NULL
C	NULL
revealed	NULL
a	NULL
4-bp	NULL
deletion	NULL
beginning	NULL
at	NULL
position	NULL
3,326	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
.	NULL

This	NULL
frame-	NULL
shift	NULL
mutation	NULL
introduces	NULL
a	NULL
premature	NULL
stop	NULL
codon	NULL
into	NULL
the	NULL
transcript	NULL
,	NULL
which	NULL
would	NULL
result	NULL
in	NULL
a	NULL
protein	NULL
of	NULL
1,074	NULL
amino	NULL
acids	NULL
as	NULL
opposed	NULL
to	NULL
the	NULL
1,130-amino	NULL
acid	NULL
wild-type	NULL
CIITA	NULL
protein	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
by	NULL
using	NULL
primers	NULL
F251	NULL
and	NULL
R212	NULL
we	NULL
were	NULL
able	NULL
to	NULL
detect	NULL
an	NULL
additional	NULL
fragment	NULL
(	NULL
fragment	NULL
D	NULL
)	NULL
,	NULL
which	NULL
contained	NULL
a	NULL
second	NULL
mutation	NULL
,	NULL
a	NULL
93-bp	NULL
in-frame	NULL
deletion	NULL
of	NULL
nucleotides	NULL
3,085-3,177	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
.	NULL

Confirmation	NULL
of	NULL
the	NULL
Mutations	NULL
in	NULL
Genomic	NULL
DNA	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
mutant	NULL
cDN	NULL
As	NULL
detected	NULL
by	NULL
RT-PCR	NULL
in	NULL
clone	NULL
13	NULL
corresponded	NULL
to	NULL
genomic	NULL
mutations	NULL
,	NULL
we	NULL
generated	NULL
a	NULL
6.6-kb	NULL
PCR	NULL
fragment	NULL
from	NULL
clone	NULL
13	NULL
genomic	NULL
DNA	NULL
,	NULL
which	NULL
spans	NULL
the	NULL
regions	NULL
in	NULL
the	NULL
cDNA	NULL
containing	NULL
both	NULL
the	NULL
93-	NULL
and	NULL
4-bp	NULL
deletions	NULL
using	NULL
primers	NULL
F246	NULL
and	NULL
R	NULL
248	NULL
.	NULL

A	NULL
similar	NULL
6.6-kb	NULL
fragment	NULL
was	NULL
generated	NULL
from	NULL
Raji	NULL
genomic	NULL
DNA	NULL
to	NULL
serve	NULL
as	NULL
a	NULL
control	NULL
for	NULL
wild-type	NULL
CIITA	NULL
.	NULL

These	NULL
ATG	NULL
Not	NULL
!	NULL

BamHI	NULL
BsaW	NULL
!	NULL

TGA	NULL
t	NULL
i	NULL
116	NULL
1340	NULL
3049	NULL
3319	NULL
3506	NULL
--	NULL
-	NULL
1	NULL
kb	NULL
AAAAAA	NULL
a	NULL
_	NULL
Re	NULL
A2	NULL
147	NULL
bp	NULL
in	NULL
frame	NULL
deletion	NULL
B	NULL
o	NULL
Â©	NULL
â_	NULL
4	NULL
bp	NULL
deletion	NULL
93	NULL
bp	NULL
in	NULL
frame	NULL
deletion	NULL
bo	NULL
-	NULL
3315	NULL
3325	NULL
3335	NULL
3345	NULL
wild	NULL
type	NULL
CIITA	NULL
ars	NULL
Ct	NULL
og	NULL
Gc	NULL
Ac	NULL
gc	NULL
IC	NULL
Cc	NULL
os	NULL
GG	NULL
AG	NULL
Gc	NULL
V	NULL
L	NULL
P	NULL
D	NULL
M	NULL
v	NULL
S	NULL
L	NULL
R	NULL
V	NULL
M	NULL
D	NULL
aa	NULL
-	NULL
1067	NULL
1070	NULL
1075	NULL
bp	NULL
3315	NULL
3325	NULL
3335	NULL
CLONE	NULL
13	NULL
CIITA	NULL
arc	NULL
CTT	NULL
o	NULL
Gac	NULL
Tor	NULL
CC	NULL
TC	NULL
Gx	NULL
TA	NULL
V	NULL
L	NULL
P	NULL
el	NULL
R	NULL
P	NULL
T	NULL
G	NULL
*	NULL
aa	NULL
-	NULL
1067	NULL
1970	NULL
1075	NULL
Figure	NULL
1	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
the	NULL
CHITA	NULL
cDNA	NULL
fragments	NULL
generated	NULL
by	NULL
RT-PCR	NULL
from	NULL
clone	NULL
13	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
primers	NULL
used	NULL
to	NULL
generate	NULL
fragments	NULL
Al	NULL
,	NULL
A2	NULL
,	NULL
B	NULL
,	NULL
C	NULL
,	NULL
and	NULL
D	NULL
are	NULL
described	NULL
in	NULL
Results	NULL
Fragments	NULL
A1	NULL
and	NULL
B	NULL
appear	NULL
to	NULL
correspond	NULL
to	NULL
wild-type	NULL
CIITA	NULL
,	NULL
whereas	NULL
fragments	NULL
C	NULL
and	NULL
D	NULL
represent	NULL
previously	NULL
undetected	NULL
deletions	NULL
in	NULL
the	NULL
CHIT	NULL
A	NULL
cDNA	NULL
.	NULL

Fragment	NULL
A2	NULL
carries	NULL
a	NULL
deletion	NULL
which	NULL
has	NULL
previously	NULL
been	NULL
detected	NULL
in	NULL
Raji	NULL
(	NULL
24	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Sequence	NULL
of	NULL
the	NULL
4-bp	NULL
mutation	NULL
detected	NULL
in	NULL
clone	NULL
13	NULL
cDNA	NULL
and	NULL
genomic	NULL
DNA	NULL
.	NULL

The	NULL
four	NULL
nucleotides	NULL
underlined	NULL
in	NULL
the	NULL
wild	NULL
type	NULL
sequence	NULL
are	NULL
deleted	NULL
in	NULL
clone	NULL
13.	NULL
fragments	NULL
were	NULL
subcloned	NULL
and	NULL
multiple	NULL
independent	NULL
isolates	NULL
were	NULL
sequenced	NULL
in	NULL
the	NULL
regions	NULL
of	NULL
both	NULL
mutations	NULL
.	NULL

We	NULL
reasoned	NULL
that	NULL
the	NULL
4-bp	NULL
deletion	NULL
detected	NULL
in	NULL
the	NULL
clone	NULL
13	NULL
cDNA	NULL
was	NULL
likely	NULL
to	NULL
result	NULL
from	NULL
a	NULL
parallel	NULL
4-bp	NULL
deletion	NULL
in	NULL
the	NULL
genomic	NULL
DNA	NULL
and	NULL
,	NULL
indeed	NULL
,	NULL
10	NULL
out	NULL
of	NULL
10	NULL
independent	NULL
genomic	NULL
isolates	NULL
sequenced	NULL
harbored	NULL
this	NULL
deletion	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
.	NULL

All	NULL
R	NULL
aji	NULL
isolates	NULL
analyzed	NULL
showed	NULL
wild-type	NULL
sequence	NULL
.	NULL

The	NULL
93-bp	NULL
deletion	NULL
mutant	NULL
cDNA	NULL
could	NULL
arise	NULL
from	NULL
three	NULL
possible	NULL
mechanisms	NULL
:	NULL
(	NULL
a	NULL
)	NULL
a	NULL
genomic	NULL
deletion	NULL
of	NULL
the	NULL
same	NULL
93	NULL
bp	NULL
,	NULL
(	NULL
b	NULL
)	NULL
a	NULL
genomic	NULL
mutation	NULL
in	NULL
a	NULL
splice	NULL
donor	NULL
or	NULL
splice	NULL
acceptor	NULL
site	NULL
that	NULL
would	NULL
result	NULL
in	NULL
exon	NULL
skipping	NULL
,	NULL
as	NULL
is	NULL
the	NULL
case	NULL
in	NULL
the	NULL
mutant	NULL
CHT	NULL
A	NULL
present	NULL
in	NULL
the	NULL
CHT	NULL
A-deficient	NULL
cell	NULL
line	NULL
BLS-2	NULL
(	NULL
13	NULL
)	NULL
or	NULL
(	NULL
d	NULL
)	NULL
a	NULL
splice	NULL
variant	NULL
similar	NULL
to	NULL
those	NULL
detected	NULL
in	NULL
Raji	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
six	NULL
independent	NULL
isolates	NULL
of	NULL
the	NULL
6.6-kb	NULL
genomic	NULL
PCR	NULL
fragment	NULL
from	NULL
clone	NULL
13	NULL
showed	NULL
that	NULL
the	NULL
93-bp	NULL
region	NULL
was	NULL
indeed	NULL
present	NULL
in	NULL
the	NULL
genome	NULL
and	NULL
that	NULL
it	NULL
constitutes	NULL
a	NULL
single	NULL
exon	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
splice	NULL
donor	NULL
and	NULL
acceptor	NULL
sites	NULL
flanking	NULL
this	NULL
exon	NULL
are	NULL
completely	NULL
wild	NULL
type	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
identical	NULL
to	NULL
Raji	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
93-bp	NULL
mutant	NULL
cDNA	NULL
in	NULL
clone	NULL
13	NULL
represents	NULL
a	NULL
splice	NULL
variant	NULL
.	NULL

1888	NULL
Cytogenetic	NULL
Analysis	NULL
of	NULL
Clone	NULL
13	NULL
.	NULL

-	NULL
Because	NULL
we	NULL
were	NULL
only	NULL
able	NULL
to	NULL
detect	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
4-bp	NULL
mutation	NULL
in	NULL
PCR	NULL
fragments	NULL
derived	NULL
from	NULL
genomic	NULL
DNA	NULL
,	NULL
we	NULL
wished	NULL
to	NULL
determine	NULL
whether	NULL
clone	NULL
13	NULL
bore	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
chromosome	NULL
16	NULL
or	NULL
whether	NULL
clone	NULL
13	NULL
was	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
diploid	NULL
for	NULL
chromosome	NULL
16	NULL
.	NULL

We	NULL
also	NULL
examined	NULL
chromosome	NULL
6	NULL
,	NULL
which	NULL
encodes	NULL
the	NULL
MHC	NULL
locus	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
performed	NULL
GTG	NULL
banding	NULL
on	NULL
chromosome	NULL
spreads	NULL
from	NULL
clone	NULL
13	NULL
.	NULL

This	NULL
analysis	NULL
suggested	NULL
that	NULL
both	NULL
chromosome	NULL
16	NULL
(	NULL
the	NULL
location	NULL
of	NULL
the	NULL
CIITA	NULL
gene	NULL
)	NULL
and	NULL
chromosome	NULL
6	NULL
(	NULL
the	NULL
location	NULL
of	NULL
the	NULL
MHC	NULL
)	NULL
were	NULL
intact	NULL
.	NULL

The	NULL
chromosomal	NULL
abnormalities	NULL
of	NULL
seven	NULL
karyo-typed	NULL
cell	NULL
from	NULL
clone	NULL
13	NULL
were	NULL
the	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
typical	NULL
of	NULL
EBV-transformed	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
and	NULL
trisomy	NULL
13	NULL
and	NULL
21	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
48	NULL
,	NULL
XY	NULL
,	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q24.1	NULL
;	NULL
q32.3	NULL
)	NULL
,	NULL
+13	NULL
,	NULL
+21	NULL
[	NULL
7	NULL
]	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
these	NULL
trisomies	NULL
is	NULL
pres	NULL
ently	NULL
unclear	NULL
and	NULL
may	NULL
represent	NULL
clonal	NULL
evolution	NULL
.	NULL

Analysis	NULL
of	NULL
chromosome	NULL
16	NULL
in	NULL
clone	NULL
13	NULL
by	NULL
whole	NULL
chromosome	NULL
painting	NULL
revealed	NULL
that	NULL
in	NULL
49	NULL
of	NULL
50	NULL
cells	NULL
examined	NULL
,	NULL
chromosome	NULL
16	NULL
was	NULL
present	NULL
in	NULL
two	NULL
copies	NULL
per	NULL
cell	NULL
and	NULL
in	NULL
one	NULL
cell	NULL
three	NULL
copies	NULL
of	NULL
chromosome	NULL
16	NULL
were	NULL
present	NULL
.	NULL

This	NULL
latter	NULL
single	NULL
cell	NULL
finding	NULL
is	NULL
defined	NULL
as	NULL
pseudomosaicism	NULL
and	NULL
is	NULL
thought	NULL
to	NULL
represent	NULL
a	NULL
technical	NULL
artifact	NULL
,	NULL
but	NULL
low	NULL
level	NULL
mo-saicism	NULL
for	NULL
trisomy	NULL
16	NULL
can	NULL
not	NULL
be	NULL
excluded	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
shows	NULL
an	NULL
analysis	NULL
of	NULL
a	NULL
typical	NULL
clone	NULL
13	NULL
cell	NULL
by	NULL
whole	NULL
chromosome	NULL
painting	NULL
for	NULL
chromosome	NULL
16	NULL
and	NULL
by	NULL
DAPI	NULL
counterstaining	NULL
.	NULL

Furthermore	NULL
,	NULL
there	NULL
was	NULL
no	NULL
evidence	NULL
for	NULL
translocation	NULL
of	NULL
part	NULL
(	NULL
s	NULL
)	NULL
of	NULL
chromosome	NULL
16	NULL
to	NULL
any	NULL
other	NULL
chromosome	NULL
,	NULL
although	NULL
small	NULL
deletion	NULL
would	NULL
not	NULL
be	NULL
detected	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
clone	NULL
13	NULL
does	NULL
carry	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
structural	NULL
gene	NULL
for	NULL
CHT	NULL
A.	NULL
Clone	NULL
13	NULL
Does	NULL
Not	NULL
Express	NULL
CIITA	NULL
Protein	NULL
.	NULL

To	NULL
examine	NULL
further	NULL
whether	NULL
the	NULL
HLA-DQ	NULL
expression	NULL
present	NULL
in	NULL
clone	NULL
13	NULL
was	NULL
due	NULL
to	NULL
CIITA	NULL
,	NULL
we	NULL
performed	NULL
immunoblotting	NULL
analysis	NULL
on	NULL
nuclear	NULL
extracts	NULL
from	NULL
clone	NULL
13	NULL
cells	NULL
transfected	NULL
with	NULL
either	NULL
pCMV.KÂ®	NULL
,	NULL
pCMV.CIHITA	NULL
,	NULL
pCMV.CHTAA4	NULL
,	NULL
pCMV.CIHITAA9Q3	NULL
,	NULL
and	NULL
pCMV.CHTAA1I47	NULL
.	NULL

Wild-type	NULL
CIHTA	NULL
has	NULL
a	NULL
calculated	NULL
molecular	NULL
mass	NULL
of	NULL
1.24	NULL
X	NULL
10Â°	NULL
kD	NULL
,	NULL
whereas	NULL
the	NULL
mutant	NULL
CHT	NULL
As	NULL
have	NULL
a	NULL
calculated	NULL
molecular	NULL
mass	NULL
of	NULL
between	NULL
1.18	NULL
and	NULL
1.21	NULL
X	NULL
10Â°	NULL
kD	NULL
.	NULL

Endogenous	NULL
CIITA	NULL
was	NULL
readily	NULL
detected	NULL
in	NULL
untransfected	NULL
R	NULL
aji	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
or	NULL
in	NULL
R	NULL
aji	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
control	NULL
plas	NULL
mid	NULL
pCMV.KÂ®	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
Raji	NULL
with	NULL
pCMV	NULL
.	NULL

CHIT	NULL
A	NULL
resulted	NULL
in	NULL
higher	NULL
levels	NULL
of	NULL
wild-type	NULL
CHT	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

In	NULL
clone	NULL
13	NULL
,	NULL
endogenous	NULL
CHT	NULL
A	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
control	NULL
plasmid	NULL
pCMV.KÂ®	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
but	NULL
transfection	NULL
with	NULL
pCMV.CHIT	NULL
A	NULL
resulted	NULL
in	NULL
the	NULL
overexpression	NULL
of	NULL
CHT	NULL
A	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
clone	NULL
13	NULL
with	NULL
either	NULL
pCMV.CIHTAA4	NULL
or	NULL
pCMV	NULL
.	NULL

CIITAA147	NULL
resulted	NULL
in	NULL
the	NULL
overexpression	NULL
of	NULL
these	NULL
truncated	NULL
mutant	NULL
forms	NULL
of	NULL
CHIT	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
7	NULL
,	NULL
respec-tively	NULL
)	NULL
,	NULL
whereas	NULL
transfection	NULL
with	NULL
pCMV.CIHITAA9Q3	NULL
did	NULL
not	NULL
result	NULL
in	NULL
the	NULL
production	NULL
of	NULL
detectable	NULL
protein	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
RJ2.2.5	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
same	NULL
panel	NULL
of	NULL
plasmids	NULL
were	NULL
examined	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
clone	NULL
13	NULL
transcribes	NULL
the	NULL
CHT	NULL
A	NULL
gene	NULL
,	NULL
we	NULL
find	NULL
no	NULL
evidence	NULL
of	NULL
endogenous	NULL
CHT	NULL
A	NULL
protein	NULL
in	NULL
clone	NULL
13	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
(	NULL
a	NULL
)	NULL
the	NULL
CHT	NULL
A	NULL
mRNA	NULL
in	NULL
clone	NULL
13	NULL
is	NULL
not	NULL
trans	NULL
An	NULL
HLA-DQ	NULL
Isotype-specific	NULL
T	NULL
ransactivator	NULL
lated	NULL
,	NULL
(	NULL
0	NULL
)	NULL
that	NULL
the	NULL
mutant	NULL
CIIT	NULL
A	NULL
protein	NULL
is	NULL
not	NULL
stable	NULL
,	NULL
or	NULL
(	NULL
c	NULL
)	NULL
that	NULL
it	NULL
is	NULL
present	NULL
but	NULL
in	NULL
levels	NULL
below	NULL
the	NULL
limits	NULL
of	NULL
detection	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
a	NULL
truncated	NULL
mutant	NULL
CHT	NULL
A	NULL
can	NULL
be	NULL
overex-pressed	NULL
from	NULL
the	NULL
plasmid	NULL
pCMV.CIHITAA4	NULL
suggests	NULL
that	NULL
the	NULL
third	NULL
possibility	NULL
is	NULL
most	NULL
likely	NULL
.	NULL

Mutant	NULL
CIHITAs	NULL
from	NULL
Clone	NULL
13	NULL
Do	NULL
Not	NULL
Adivate	NULL
HLA-DQ	NULL
Expression	NULL
.	NULL

-	NULL
In	NULL
the	NULL
event	NULL
that	NULL
CIITA	NULL
protein	NULL
was	NULL
present	NULL
in	NULL
clone	NULL
13	NULL
but	NULL
was	NULL
present	NULL
at	NULL
levels	NULL
too	NULL
low	NULL
to	NULL
detect	NULL
,	NULL
we	NULL
constructed	NULL
chimeric	NULL
CHT	NULL
A	NULL
cDNAs	NULL
bearing	NULL
the	NULL
clone	NULL
13	NULL
CIHTA	NULL
mutations	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
wild-type	NULL
CHT	NULL
A	NULL
cDNA	NULL
.	NULL

These	NULL
chimeric	NULL
cDNAs	NULL
were	NULL
cloned	NULL
into	NULL
pCEP4	NULL
,	NULL
an	NULL
episomally	NULL
maintained	NULL
expression	NULL
vector	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

All	NULL
expression	NULL
constructs	NULL
were	NULL
stably	NULL
introduced	NULL
into	NULL
RJ2.2.5	NULL
,	NULL
a	NULL
CIHITA-deficient	NULL
cell	NULL
line	NULL
that	NULL
maps	NULL
to	NULL
MHC	NULL
class	NULL
II	NULL
CID	NULL
complementation	NULL
group	NULL
II	NULL
and	NULL
fails	NULL
to	NULL
express	NULL
all	NULL
class	NULL
II	NULL
antigens	NULL
.	NULL

We	NULL
reasoned	NULL
that	NULL
if	NULL
CIHTA	NULL
were	NULL
directly	NULL
responsible	NULL
for	NULL
the	NULL
pattern	NULL
of	NULL
HLA	NULL
Q1234567	NULL
71	NULL
unes	NULL
an	NULL
an	NULL
=	NULL
:	NULL
*	NULL
:	NULL
Figure	NULL
3	NULL
.	NULL

-	NULL
Lack	NULL
of	NULL
expression	NULL
of	NULL
CHT	NULL
A	NULL
protein	NULL
in	NULL
clone	NULL
13	NULL
.	NULL

R	NULL
aji	NULL
(	NULL
lanes	NULL
1-2	NULL
)	NULL
and	NULL
clone	NULL
13	NULL
cells	NULL
(	NULL
lanes	NULL
3-7	NULL
)	NULL
were	NULL
stably	NULL
transfected	NULL
with	NULL
either	NULL
pCMV.KÂ®	NULL
(	NULL
lanes	NULL
I	NULL
and	NULL
3	NULL
)	NULL
,	NULL
pCMV.CIHITA	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
,	NULL
pCMV	NULL
.	NULL

CIHTAA4	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
pCMV.CIHITAA93	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
or	NULL
pCMV.CIHITAA1I47	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
using	NULL
a	NULL
cocktail	NULL
of	NULL
three	NULL
murine	NULL
anti-CIIT	NULL
A	NULL
mAbs	NULL
.	NULL

CHIT	NULL
A	NULL
is	NULL
not	NULL
detected	NULL
in	NULL
clone	NULL
13	NULL
transfected	NULL
with	NULL
pCMV.KÂ®	NULL
,	NULL
but	NULL
is	NULL
readily	NULL
detected	NULL
in	NULL
Raji	NULL
cells	NULL
transfected	NULL
with	NULL
pCMV.KÂ®	NULL
.	NULL

The	NULL
upper	NULL
arrow	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
wild-type	NULL
CHIT	NULL
A	NULL
,	NULL
while	NULL
the	NULL
lower	NULL
arrow	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
the	NULL
truncated	NULL
CIITA	NULL
proteins	NULL
encoded	NULL
by	NULL
pCMV.CIHITAA4	NULL
and	NULL
pCMV	NULL
.	NULL

CHTAA147	NULL
.	NULL

1889	NULL
Douhan	NULL
et	NULL
al	NULL
.	NULL

Figure	NULL
2	NULL
.	NULL

-	NULL
Chromosome	NULL
painting	NULL
for	NULL
chromosome	NULL
16	NULL
.	NULL

Cells	NULL
were	NULL
painted	NULL
for	NULL
chromosome	NULL
16	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
image	NULL
on	NULL
the	NULL
left	NULL
shows	NULL
a	NULL
cell	NULL
painted	NULL
for	NULL
chromosome	NULL
16	NULL
.	NULL

Two	NULL
copies	NULL
of	NULL
chromosome	NULL
16	NULL
are	NULL
evident	NULL
in	NULL
this	NULL
cell	NULL
.	NULL

No	NULL
translocations	NULL
,	NULL
inser-tions	NULL
,	NULL
or	NULL
other	NULL
rearrangements	NULL
of	NULL
chromosome	NULL
16	NULL
are	NULL
observed	NULL
.	NULL

The	NULL
image	NULL
on	NULL
the	NULL
right	NULL
is	NULL
the	NULL
corresponding	NULL
DAPI	NULL
image	NULL
(	NULL
for	NULL
chromosome	NULL
identification	NULL
)	NULL
of	NULL
the	NULL
image	NULL
on	NULL
the	NULL
left	NULL
.	NULL

class	NULL
II	NULL
expression	NULL
in	NULL
clone	NULL
13	NULL
(	NULL
HLA-DR	NULL
-	NULL
,	NULL
-DQ	NULL
*	NULL
,	NULL
-DP7	NULL
)	NULL
,	NULL
that	NULL
CIITA	NULL
might	NULL
also	NULL
function	NULL
similarly	NULL
in	NULL
another	NULL
CIIT	NULL
A-deficient	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
various	NULL
chimeric	NULL
CIHTA	NULL
cDNAs	NULL
used	NULL
for	NULL
these	NULL
transfection	NULL
studies	NULL
and	NULL
the	NULL
results	NULL
of	NULL
flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
R	NULL
J2.2.5	NULL
cells	NULL
transfected	NULL
with	NULL
either	NULL
pCMV.CIIT	NULL
A	NULL
,	NULL
or	NULL
with	NULL
the	NULL
chimeric	NULL
constructs	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

As	NULL
shown	NULL
previously	NULL
,	NULL
transfection	NULL
of	NULL
wild-type	NULL
CIITA	NULL
into	NULL
RJ2.2.5	NULL
caused	NULL
reexpression	NULL
of	NULL
HLA-DR	NULL
,	NULL
-DQ	NULL
,	NULL
and	NULL
-DP	NULL
.	NULL

Notably	NULL
,	NULL
chimeric	NULL
CHT	NULL
A	NULL
cDNAs	NULL
bearing	NULL
either	NULL
the	NULL
4-bp	NULL
or	NULL
the	NULL
93-bp	NULL
deletion	NULL
were	NULL
unable	NULL
to	NULL
recapitulate	NULL
the	NULL
pattern	NULL
of	NULL
HLA-D	NULL
antigen	NULL
expression	NULL
seen	NULL
in	NULL
clone	NULL
13	NULL
.	NULL

Inter-estingly	NULL
,	NULL
a	NULL
CIITA	NULL
cDNA	NULL
bearing	NULL
the	NULL
147-bp	NULL
deletion	NULL
previously	NULL
identified	NULL
as	NULL
a	NULL
splice	NULL
variant	NULL
was	NULL
fully	NULL
active	NULL
,	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
deletion	NULL
region	NULL
maps	NULL
to	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
Chimeric	NULL
CIITA	NULL
cDNA	NULL
constructs	NULL
Class	NULL
I1	NULL
expression	NULL
Not	NULL
!	NULL

BamHI	NULL
-	NULL
BsaW	NULL
!	NULL

DR	NULL
CQ	NULL
CP	NULL
+	NULL
+	NULL
+	NULL
o	NULL
___	NULL
BMM	NULL
o	NULL
Ir	NULL
___	NULL
+	NULL
+	NULL
+	NULL
I	NULL
wild	NULL
type	NULL
clone	NULL
13	NULL
s	NULL
B	NULL
Figure	NULL
4	NULL
.	NULL

MHC	NULL
class	NULL
II	NULL
expression	NULL
directed	NULL
by	NULL
chimeric	NULL
CHT	NULL
A	NULL
cDNAs	NULL
tranfected	NULL
into	NULL
RJ	NULL
2.2.5	NULL
cells	NULL
.	NULL

Expression	NULL
plasmids	NULL
bearing	NULL
chimeric	NULL
CHTA	NULL
cDNA	NULL
derived	NULL
from	NULL
the	NULL
indicated	NULL
sources	NULL
were	NULL
stably	NULL
transfected	NULL
into	NULL
RJ2.2.5	NULL
cells	NULL
and	NULL
analyzed	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
HLA-DR	NULL
,	NULL
-DP	NULL
,	NULL
and	NULL
-DQ	NULL
after	NULL
selection	NULL
in	NULL
hygromycin	NULL
.	NULL

Surface	NULL
expression	NULL
of	NULL
HLA	NULL
antigens	NULL
was	NULL
detected	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

proline-serine-threonine	NULL
(	NULL
PST	NULL
)	NULL
-rich	NULL
domain	NULL
that	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
optimal	NULL
transactivaton	NULL
by	NULL
CHT	NULL
A	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
mutations	NULL
in	NULL
CHT	NULL
A	NULL
in	NULL
the	NULL
clone	NULL
13	NULL
alleles	NULL
rendered	NULL
them	NULL
completely	NULL
unable	NULL
to	NULL
transactivate	NULL
all	NULL
three	NULL
HLA-D	NULL
genes	NULL
.	NULL

These	NULL
data	NULL
suggested	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
HLA-DQ	NULL
in	NULL
clone	NULL
13	NULL
may	NULL
be	NULL
regulated	NULL
by	NULL
a	NULL
novel	NULL
tuns	NULL
acting	NULL
factor	NULL
different	NULL
from	NULL
and	NULL
independent	NULL
of	NULL
CHT	NULL
A	NULL
.	NULL

An	NULL
HLA-DQ	NULL
Transadivator	NULL
Is	NULL
Present	NULL
in	NULL
Clone	NULL
13	NULL
.	NULL

-	NULL
To	NULL
provide	NULL
direct	NULL
evidence	NULL
for	NULL
an	NULL
HLA-DQ	NULL
isotype-specific	NULL
transacting	NULL
factor	NULL
in	NULL
clone	NULL
13	NULL
,	NULL
we	NULL
designed	NULL
a	NULL
somatic	NULL
cell	NULL
fusion	NULL
experiment	NULL
between	NULL
clone	NULL
13	NULL
and	NULL
another	NULL
CIIT	NULL
A-deficient	NULL
cell	NULL
line	NULL
,	NULL
RJ2.2.5	NULL
,	NULL
taking	NULL
advantage	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
these	NULL
two	NULL
cell	NULL
lines	NULL
have	NULL
different	NULL
DQB	NULL
haplotypes	NULL
as	NULL
determined	NULL
by	NULL
DNA-based	NULL
tissue	NULL
typing	NULL
.	NULL

Clone	NULL
13	NULL
is	NULL
DQB1*0602	NULL
(	NULL
DQ6	NULL
)	NULL
and	NULL
DQB1*0301	NULL
(	NULL
DQ	NULL
3	NULL
)	NULL
,	NULL
whereas	NULL
R	NULL
J2.2.5	NULL
is	NULL
DQB1*0501	NULL
(	NULL
DQ5	NULL
)	NULL
and	NULL
DQB1*0201	NULL
(	NULL
DQ2	NULL
)	NULL
.	NULL

We	NULL
reasoned	NULL
that	NULL
if	NULL
clone	NULL
13	NULL
has	NULL
a	NULL
factor	NULL
capable	NULL
of	NULL
specifically	NULL
activating	NULL
the	NULL
HLA-DQ	NULL
genes	NULL
,	NULL
it	NULL
should	NULL
be	NULL
able	NULL
to	NULL
reactivate	NULL
expression	NULL
of	NULL
DQ	NULL
in	NULL
another	NULL
CIIT	NULL
A-deficient	NULL
cell	NULL
line	NULL
from	NULL
group	NULL
II	NULL
CID	NULL
upon	NULL
fusion	NULL
of	NULL
these	NULL
two	NULL
cells	NULL
.	NULL

This	NULL
strategy	NULL
is	NULL
outlined	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
R	NULL
J2.2.5	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
pCMV.KÂ®	NULL
,	NULL
an	NULL
episomally	NULL
maintained	NULL
vector	NULL
that	NULL
expresses	NULL
KÂ®	NULL
,	NULL
a	NULL
murine	NULL
class	NULL
I	NULL
molecule	NULL
,	NULL
and	NULL
confers	NULL
hygromycin	NULL
resistance	NULL
were	NULL
fused	NULL
to	NULL
clone	NULL
13	NULL
cells	NULL
transfected	NULL
with	NULL
pREP9.D5	NULL
,	NULL
a	NULL
second	NULL
episomally	NULL
maintained	NULL
vector	NULL
,	NULL
which	NULL
directs	NULL
the	NULL
expression	NULL
of	NULL
DS	NULL
,	NULL
another	NULL
murine	NULL
class	NULL
I	NULL
antigen	NULL
,	NULL
and	NULL
confers	NULL
neomycin	NULL
resistance	NULL
.	NULL

Both	NULL
R	NULL
J2.2.5/	NULL
KÂ®	NULL
and	NULL
clone	NULL
13/	NULL
DS	NULL
retain	NULL
the	NULL
pattern	NULL
of	NULL
class	NULL
II	NULL
expression	NULL
as	NULL
seen	NULL
in	NULL
R	NULL
J2.2.5	NULL
and	NULL
clone	NULL
13	NULL
,	NULL
respectively	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
fusion	NULL
was	NULL
then	NULL
selected	NULL
in	NULL
both	NULL
hygromycin	NULL
and	NULL
neomycin	NULL
to	NULL
generate	NULL
a	NULL
population	NULL
of	NULL
stable	NULL
RJ2.2.5/KÂ®	NULL
by	NULL
clone	NULL
13/	NULL
D4	NULL
fusion	NULL
products	NULL
.	NULL

This	NULL
population	NULL
was	NULL
analyzed	NULL
by	NULL
three-color	NULL
flow	NULL
cytometry	NULL
by	NULL
staining	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
KÂ®Â°	NULL
,	NULL
DG	NULL
,	NULL
and	NULL
DQ2	NULL
.	NULL

Because	NULL
each	NULL
fusion	NULL
partner	NULL
expresses	NULL
a	NULL
different	NULL
murine	NULL
class	NULL
I	NULL
antigen	NULL
,	NULL
the	NULL
fused	NULL
cells	NULL
can	NULL
be	NULL
detected	NULL
as	NULL
staining	NULL
doubly	NULL
for	NULL
KÂ®Â°	NULL
and	NULL
DS	NULL
.	NULL

These	NULL
double-positive	NULL
cells	NULL
can	NULL
then	NULL
be	NULL
specifically	NULL
examined	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
DQ	NULL
2	NULL
,	NULL
one	NULL
of	NULL
the	NULL
allelic	NULL
forms	NULL
of	NULL
DQ	NULL
encoded	NULL
by	NULL
R	NULL
J2.2.5	NULL
.	NULL

The	NULL
results	NULL
of	NULL
such	NULL
a	NULL
triple-color	NULL
analysis	NULL
performed	NULL
on	NULL
a	NULL
population	NULL
of	NULL
stably	NULL
fused	NULL
cells	NULL
is	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Fig	NULL
.	NULL

6	NULL
A	NULL
shows	NULL
a	NULL
large	NULL
number	NULL
of	NULL
cells	NULL
(	NULL
52	NULL
%	NULL
)	NULL
that	NULL
stain	NULL
for	NULL
both	NULL
KÂ®Â°	NULL
(	NULL
PE	NULL
)	NULL
and	NULL
DG	NULL
(	NULL
FITC	NULL
)	NULL
.	NULL

When	NULL
the	NULL
KÂ°D4	NULL
double-positive	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
,	NULL
upper	NULL
right	NULL
hand	NULL
quadrant	NULL
)	NULL
which	NULL
were	NULL
also	NULL
stained	NULL
for	NULL
DQ2	NULL
were	NULL
compared	NULL
with	NULL
the	NULL
KÂ°DÂ¢	NULL
double-positive	NULL
cells	NULL
stained	NULL
with	NULL
an	NULL
isotype-matched	NULL
control	NULL
antibody	NULL
a	NULL
clear	NULL
shift	NULL
in	NULL
fluorescence	NULL
intensity	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
.	NULL

No	NULL
expression	NULL
of	NULL
either	NULL
HLA-DR	NULL
or	NULL
HLA-DP	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
fused	NULL
cell	NULL
population	NULL
,	NULL
demonstrating	NULL
the	NULL
isotype	NULL
specificity	NULL
of	NULL
this	NULL
trams-acting	NULL
factor	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
DQ2	NULL
in	NULL
the	NULL
stable	NULL
cell	NULL
fusions	NULL
,	NULL
we	NULL
were	NULL
also	NULL
able	NULL
to	NULL
detect	NULL
HLA-DQ2	NULL
mRNA	NULL
in	NULL
the	NULL
fusions	NULL
by	NULL
RT-PCR	NULL
.	NULL

RNA	NULL
prepared	NULL
from	NULL
two	NULL
separate	NULL
somatic	NULL
cell	NULL
fusion	NULL
experiments	NULL
,	NULL
from	NULL
the	NULL
individual	NULL
fusion	NULL
partners	NULL
,	NULL
RJ2.2.5	NULL
and	NULL
clone	NULL
13	NULL
,	NULL
and	NULL
from	NULL
R	NULL
aji	NULL
(	NULL
the	NULL
class	NULL
II-positive	NULL
cell	NULL
line	NULL
from	NULL
which	NULL
RJ2.2.5	NULL
was	NULL
derived	NULL
)	NULL
,	NULL
was	NULL
DNAse	NULL
I	NULL
treated	NULL
and	NULL
reverse	NULL
transcribed	NULL
.	NULL

The	NULL
resulting	NULL
first-strand	NULL
cDNA	NULL
was	NULL
used	NULL
as	NULL
a	NULL
template	NULL
in	NULL
1890	NULL
(	NULL
DQ2	NULL
,	NULL
DQ5	NULL
)	NULL
(	NULL
DQ3	NULL
,	NULL
DQ6	NULL
)	NULL
/	NULL
\	NULL
Transfect	NULL
with	NULL
murine	NULL
class	NULL
|	NULL
cDNAs	NULL
contained	NULL
in	NULL
EBV-episomal	NULL
vectors	NULL
with	NULL
different	NULL
drug	NULL
.	NULL

markers	NULL
\	NULL
/	NULL
RJ2.2.5	NULL
KP-hygro	NULL
CLONE13	NULL
DJ-neo	NULL
/	NULL
\	NULL
PEG-mediated	NULL
-	NULL
fusion	NULL
and	NULL
selection	NULL
in	NULL
hygro	NULL
and	NULL
neo	NULL
b	NULL
pd	NULL
RJ	NULL
2.2.5	NULL
x	NULL
CLONE	NULL
18	NULL
(	NULL
hygro	NULL
and	NULL
neo	NULL
resistant	NULL
)	NULL
Daz2t	NULL
?	NULL

Examine	NULL
KP	NULL
and	NULL
DJ	NULL
double-positive	NULL
cells	NULL
for	NULL
expression	NULL
of	NULL
DQ2	NULL
by	NULL
FACSÂ®	NULL
Figure	NULL
5	NULL
.	NULL

Does	NULL
clone	NULL
13	NULL
express	NULL
a	NULL
DQ-specific	NULL
transactivator	NULL
?	NULL

Schema	NULL
of	NULL
the	NULL
protocol	NULL
used	NULL
to	NULL
generate	NULL
stable	NULL
fusions	NULL
between	NULL
RJ	NULL
2.2.5/KÂ®	NULL
and	NULL
clone	NULL
13/	NULL
D4	NULL
.	NULL

R	NULL
J2.2.5	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
pCMV.KÂ®	NULL
and	NULL
clone	NULL
13	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
pREP.DÂ¢	NULL
were	NULL
fused	NULL
and	NULL
grown	NULL
in	NULL
both	NULL
hygromycin	NULL
and	NULL
neomycin	NULL
to	NULL
select	NULL
for	NULL
fused	NULL
cells	NULL
.	NULL

After	NULL
selection	NULL
,	NULL
the	NULL
fused	NULL
cell	NULL
population	NULL
was	NULL
analyzed	NULL
for	NULL
expression	NULL
of	NULL
DQ2	NULL
by	NULL
FACSÂ®	NULL
and	NULL
by	NULL
RT-PCR	NULL
.	NULL

An	NULL
HLA-DQ	NULL
specific	NULL
T	NULL
ransactivator	NULL
A	NULL
104	NULL
3	NULL
10.	NULL
a	NULL
2	NULL
wo	NULL
10Â°	NULL
,	NULL
10	NULL
}	NULL
10Â°	NULL
{	NULL
--	NULL
a	NULL
10Â°	NULL
10Â°	NULL
104	NULL
B	NULL
400	NULL
t	NULL
a	NULL
E	NULL
l	NULL
p	NULL
Â©	NULL
G	NULL
p	NULL
dussraÂ®	NULL
10Â°	NULL
10	NULL
'	NULL
10Â°	NULL
10Â°	NULL
10+	NULL
Fluorescence	NULL
Intensity	NULL
Figure	NULL
6	NULL
.	NULL

-	NULL
Stable	NULL
fusions	NULL
of	NULL
RJ	NULL
2.2.5/	NULL
KÂ®	NULL
and	NULL
clone	NULL
13/DÂ°	NULL
express	NULL
DQ2	NULL
on	NULL
the	NULL
surface	NULL
.	NULL

(	NULL
A	NULL
)	NULL
RJ2.2.5/KÂ®	NULL
X	NULL
clone	NULL
13/	NULL
D4	NULL
fused	NULL
cell	NULL
populations	NULL
were	NULL
triply	NULL
stained	NULL
with	NULL
antibodies	NULL
for	NULL
KÂ®	NULL
,	NULL
DG	NULL
,	NULL
and	NULL
with	NULL
either	NULL
a	NULL
mAb	NULL
(	NULL
IgM	NULL
)	NULL
specific	NULL
for	NULL
DQ2	NULL
or	NULL
with	NULL
a	NULL
control	NULL
IgM	NULL
and	NULL
analyzed	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
KÂ®	NULL
and	NULL
DS	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Cells	NULL
that	NULL
were	NULL
positive	NULL
for	NULL
both	NULL
of	NULL
these	NULL
markers	NULL
were	NULL
further	NULL
analyzed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
DQ2	NULL
.	NULL

The	NULL
unshaded	NULL
peak	NULL
represents	NULL
KÂ°*D+*	NULL
cells	NULL
stained	NULL
with	NULL
an	NULL
isotype	NULL
control	NULL
antibody	NULL
,	NULL
while	NULL
the	NULL
shaded	NULL
peak	NULL
represents	NULL
those	NULL
KÂ®*DÂ¢+*	NULL
cells	NULL
stained	NULL
with	NULL
a	NULL
reagent	NULL
specific	NULL
for	NULL
DQ2	NULL
.	NULL

PCR	NULL
reactions	NULL
with	NULL
group-specific	NULL
primers	NULL
that	NULL
amplify	NULL
a	NULL
region	NULL
from	NULL
exon	NULL
2	NULL
of	NULL
the	NULL
HLA-DQBI1	NULL
gene	NULL
(	NULL
23a	NULL
)	NULL
.	NULL

One	NULL
set	NULL
of	NULL
primers	NULL
(	NULL
GH28NL	NULL
and	NULL
QB204	NULL
)	NULL
generates	NULL
a	NULL
237	NULL
bp	NULL
product	NULL
specific	NULL
for	NULL
the	NULL
DQ	NULL
w2,3,4	NULL
alleles	NULL
,	NULL
whereas	NULL
the	NULL
second	NULL
set	NULL
(	NULL
GH28NL	NULL
and	NULL
Q	NULL
B202	NULL
)	NULL
amplifies	NULL
a	NULL
237-bp	NULL
fragment	NULL
specific	NULL
for	NULL
the	NULL
DQw1	NULL
allele	NULL
.	NULL

DQ	NULL
alleles	NULL
can	NULL
be	NULL
further	NULL
distinguished	NULL
by	NULL
taking	NULL
advantage	NULL
of	NULL
restriction	NULL
site	NULL
polymorphisms	NULL
that	NULL
occur	NULL
among	NULL
the	NULL
individual	NULL
DQ	NULL
alleles	NULL
.	NULL

Again	NULL
,	NULL
we	NULL
chose	NULL
to	NULL
look	NULL
at	NULL
the	NULL
expression	NULL
of	NULL
DQ	NULL
2	NULL
in	NULL
the	NULL
fused	NULL
populations	NULL
because	NULL
RT-PCR	NULL
experiments	NULL
showed	NULL
that	NULL
RJ2.2.5	NULL
was	NULL
slightly	NULL
leaky	NULL
for	NULL
the	NULL
transcription	NULL
of	NULL
DQB*	NULL
0501	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
but	NULL
did	NULL
not	NULL
express	NULL
any	NULL
DQB*0201	NULL
.	NULL

In	NULL
populations	NULL
of	NULL
stable	NULL
fusions	NULL
between	NULL
RJ2.2.5/KÂ®	NULL
and	NULL
clone	NULL
13/	NULL
D54	NULL
,	NULL
the	NULL
DQ	NULL
group-specific	NULL
primers	NULL
would	NULL
be	NULL
expected	NULL
to	NULL
amplify	NULL
both	NULL
a	NULL
product	NULL
from	NULL
the	NULL
DQB*	NULL
0301	NULL
gene	NULL
expressed	NULL
by	NULL
clone	NULL
13	NULL
and	NULL
a	NULL
product	NULL
from	NULL
the	NULL
DQB*0201	NULL
gene	NULL
of	NULL
R	NULL
J2.2.5	NULL
if	NULL
it	NULL
is	NULL
reexpressed	NULL
.	NULL

These	NULL
two	NULL
products	NULL
can	NULL
be	NULL
distinguished	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
their	NULL
sensitivity	NULL
to	NULL
digestion	NULL
by	NULL
the	NULL
restriction	NULL
endonucleases	NULL
FokI	NULL
and	NULL
Bgll	NULL
:	NULL
the	NULL
DQB*0201	NULL
product	NULL
is	NULL
cut	NULL
by	NULL
FokI	NULL
but	NULL
not	NULL
by	NULL
Bgll	NULL
,	NULL
whereas	NULL
the	NULL
DQB*0301	NULL
product	NULL
is	NULL
cut	NULL
by	NULL
Bgll	NULL
but	NULL
not	NULL
by	NULL
FokI	NULL
.	NULL

Fig	NULL
.	NULL

7	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
such	NULL
an	NULL
analysis	NULL
The	NULL
1891	NULL
Douhan	NULL
et	NULL
al	NULL
.	NULL

RT-PCR	NULL
products	NULL
generated	NULL
by	NULL
group-specific	NULL
primers	NULL
for	NULL
DQw2,3,4	NULL
from	NULL
the	NULL
various	NULL
cell	NULL
populations	NULL
were	NULL
either	NULL
left	NULL
uncut	NULL
or	NULL
digested	NULL
with	NULL
FokI	NULL
or	NULL
Bgll	NULL
.	NULL

Transcripts	NULL
derived	NULL
from	NULL
both	NULL
the	NULL
DQB*0201	NULL
and	NULL
the	NULL
DQB*0301	NULL
alleles	NULL
were	NULL
detected	NULL
in	NULL
all	NULL
three	NULL
populations	NULL
of	NULL
stably	NULL
fused	NULL
cells	NULL
whereas	NULL
clone	NULL
13	NULL
alone	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
transcribed	NULL
only	NULL
the	NULL
DQB*0301	NULL
allele	NULL
.	NULL

No	NULL
transcription	NULL
of	NULL
the	NULL
DQB*0201	NULL
gene	NULL
was	NULL
detected	NULL
in	NULL
R	NULL
J2.2.5	NULL
in	NULL
contrast	NULL
with	NULL
its	NULL
presence	NULL
in	NULL
the	NULL
class	NULL
II-positive	NULL
parent	NULL
,	NULL
R	NULL
aji	NULL
.	NULL

Discussion	NULL
Here	NULL
,	NULL
we	NULL
have	NULL
analyzed	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
unusual	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
antigens	NULL
in	NULL
a	NULL
mutant	NULL
B-lymphoblastoid	NULL
cell	NULL
line	NULL
,	NULL
clone	NULL
13	NULL
.	NULL

Clone	NULL
13	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
by	NULL
complementation	NULL
analysis	NULL
to	NULL
belong	NULL
to	NULL
group	NULL
II	NULL
of	NULL
the	NULL
five	NULL
known	NULL
groups	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
CID	NULL
.	NULL

Unlike	NULL
the	NULL
other	NULL
cell	NULL
lines	NULL
in	NULL
this	NULL
complementation	NULL
group	NULL
,	NULL
which	NULL
fail	NULL
to	NULL
transcribe	NULL
all	NULL
class	NULL
II	NULL
genes	NULL
,	NULL
clone	NULL
13	NULL
does	NULL
express	NULL
substantial	NULL
levels	NULL
of	NULL
HLA-DQ	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
HLA-DR	NULL
and	NULL
-DP	NULL
expression	NULL
.	NULL

It	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
gene	NULL
defective	NULL
in	NULL
complementation	NULL
group	NULL
II	NULL
cells	NULL
is	NULL
CHT	NULL
A	NULL
,	NULL
and	NULL
ectopic	NULL
expression	NULL
of	NULL
CIIT	NULL
A	NULL
in	NULL
these	NULL
cells	NULL
is	NULL
both	NULL
necessary	NULL
and	NULL
sufficient	NULL
to	NULL
restore	NULL
expression	NULL
of	NULL
all	NULL
three	NULL
HLA-D	NULL
isotypes	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
CIITA	NULL
in	NULL
clone	NULL
13	NULL
similarly	NULL
restores	NULL
HLA-DR	NULL
and	NULL
-DP	NULL
and	NULL
increases	NULL
HLA-DQ	NULL
expression	NULL
.	NULL

One	NULL
possible	NULL
explanation	NULL
for	NULL
the	NULL
clone	NULL
13	NULL
phenotype	NULL
was	NULL
that	NULL
one	NULL
allele	NULL
of	NULL
CHIT	NULL
A	NULL
in	NULL
clone	NULL
13	NULL
harbored	NULL
a	NULL
mutation	NULL
that	NULL
abrogated	NULL
HLA-DR	NULL
and	NULL
-DP	NULL
but	NULL
not	NULL
HLA-DQ	NULL
transcription	NULL
.	NULL

We	NULL
have	NULL
detected	NULL
a	NULL
4-bp	NULL
genomic	NULL
deletion	NULL
in	NULL
at	NULL
least	NULL
one	NULL
allele	NULL
of	NULL
CHT	NULL
A	NULL
in	NULL
clone	NULL
13	NULL
;	NULL
however	NULL
,	NULL
this	NULL
gene	NULL
is	NULL
functionally	NULL
inert	NULL
when	NULL
introduced	NULL
into	NULL
CHT	NULL
A-deficient	NULL
cell	NULL
lines	NULL
.	NULL

Because	NULL
we	NULL
repeatedly	NULL
isolated	NULL
only	NULL
this	NULL
mutation	NULL
from	NULL
genomic	NULL
DNA	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
both	NULL
alleles	NULL
of	NULL
the	NULL
CIITA	NULL
gene	NULL
in	NULL
clone	NULL
13	NULL
bear	NULL
this	NULL
4-bp	NULL
mutation	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
the	NULL
4-bp	NULL
deletion	NULL
represents	NULL
only	NULL
one	NULL
allelic	NULL
form	NULL
of	NULL
CITA	NULL
in	NULL
clone	NULL
13	NULL
and	NULL
that	NULL
the	NULL
other	NULL
allele	NULL
of	NULL
the	NULL
CIITA	NULL
gene	NULL
is	NULL
deleted	NULL
as	NULL
is	NULL
the	NULL
case	NULL
in	NULL
R	NULL
J2.2.5	NULL
.	NULL

It	NULL
may	NULL
be	NULL
that	NULL
the	NULL
93	NULL
bp	NULL
deletion	NULL
mutant	NULL
represents	NULL
the	NULL
second	NULL
allele	NULL
of	NULL
the	NULL
CHT	NULL
A	NULL
gene	NULL
in	NULL
clone	NULL
13	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
wild-type	NULL
splice	NULL
donor	NULL
and	NULL
acceptor	NULL
site	NULL
.	NULL

The	NULL
defects	NULL
in	NULL
CHT	NULL
A	NULL
found	NULL
in	NULL
other	NULL
group	NULL
II	NULL
cell	NULL
lines	NULL
have	NULL
been	NULL
identified	NULL
and	NULL
include	NULL
both	NULL
in-frame	NULL
deletions	NULL
due	NULL
to	NULL
splice	NULL
donor	NULL
site	NULL
mutations	NULL
and	NULL
mutations	NULL
,	NULL
which	NULL
introduce	NULL
premature	NULL
termination	NULL
codons	NULL
as	NULL
well	NULL
as	NULL
large	NULL
genomic	NULL
deletions	NULL
(	NULL
12	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Like	NULL
the	NULL
mutations	NULL
in	NULL
clone	NULL
13	NULL
,	NULL
these	NULL
defects	NULL
are	NULL
most	NULL
often	NULL
located	NULL
in	NULL
the	NULL
3	NULL
'	NULL
portion	NULL
of	NULL
the	NULL
CHT	NULL
A	NULL
cDNA	NULL
.	NULL

In	NULL
any	NULL
case	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
there	NULL
is	NULL
no	NULL
CIITA	NULL
protein	NULL
detectable	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
in	NULL
clone	NULL
13	NULL
and	NULL
,	NULL
furthermore	NULL
,	NULL
that	NULL
overexpression	NULL
of	NULL
the	NULL
clone	NULL
13	NULL
cDN	NULL
As	NULL
in	NULL
a	NULL
CHT	NULL
A-deficient	NULL
cell	NULL
line	NULL
such	NULL
as	NULL
R	NULL
J2.2.5	NULL
or	NULL
in	NULL
clone	NULL
13	NULL
itself	NULL
,	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
HLA-DQ	NULL
.	NULL

Instead	NULL
,	NULL
stable	NULL
cell	NULL
fusions	NULL
between	NULL
clone	NULL
13	NULL
and	NULL
RJ2.2.5	NULL
,	NULL
restored	NULL
expression	NULL
of	NULL
the	NULL
RJ2.2.5	NULL
HLA-DQ	NULL
genes	NULL
,	NULL
providing	NULL
strong	NULL
evidence	NULL
that	NULL
clone	NULL
13	NULL
possesses	NULL
an	NULL
HLA-DQ-specific	NULL
transactivator	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
data	NULL
pre-	NULL
Figure	NULL
7	NULL
.	NULL

DQ2	NULL
expression	NULL
in	NULL
fusions	NULL
detected	NULL
by	NULL
RT-PCR	NULL
.	NULL

RNA	NULL
from	NULL
the	NULL
indicated	NULL
cell	NULL
populaton	NULL
was	NULL
reverse	NULL
transcribed	NULL
and	NULL
used	NULL
as	NULL
a	NULL
template	NULL
for	NULL
Fusion	NULL
I	NULL
Fusion	NULL
II	NULL
RJ2.2.5	NULL
Clone	NULL
13	NULL
Raji	NULL
PCR	NULL
using	NULL
DQw2,3,4	NULL
group-specific	NULL
primers	NULL
.	NULL

Por-enzyme	NULL
!	NULL

1T	NULL
Ir	NULL
11	NULL
I	NULL
tions	NULL
of	NULL
the	NULL
reactions	NULL
were	NULL
left	NULL
uncut	NULL
(	NULL
U	NULL
)	NULL
or	NULL
were	NULL
y	NULL
digested	NULL
with	NULL
either	NULL
FokI	NULL
(	NULL
F	NULL
)	NULL
or	NULL
with	NULL
Bell	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Di	NULL
t	NULL
%	NULL
ion	NULL
/	NULL
PIM	NULL
:	NULL
annette	NULL
f	NULL
E	NULL
gestion	NULL
of	NULL
the	NULL
PCR	NULL
product	NULL
by	NULL
FokI	NULL
is	NULL
indicative	NULL
of	NULL
Gla	NULL
transcripts	NULL
derived	NULL
from	NULL
the	NULL
DQBI1*0201	NULL
allele	NULL
-i	NULL
Â»	NULL
|	NULL
wth	NULL
*C	NULL
~	NULL
me	NULL
b	NULL
(	NULL
specific	NULL
to	NULL
RJ2.2.5	NULL
)	NULL
,	NULL
whereas	NULL
digestion	NULL
by	NULL
Bgll	NULL
is	NULL
-m	NULL
wms	NULL
med	NULL
i	NULL
\em	NULL
indicative	NULL
of	NULL
transcripts	NULL
derived	NULL
from	NULL
the	NULL
-	NULL
DQB1*0301	NULL
allele	NULL
(	NULL
specific	NULL
to	NULL
clone	NULL
13	NULL
)	NULL
.	NULL

sented	NULL
above	NULL
,	NULL
this	NULL
transactivator	NULL
is	NULL
not	NULL
CHT	NULL
A	NULL
and	NULL
,	NULL
further	NULL
,	NULL
functions	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CHIT	NULL
A	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
this	NULL
HLA-DQ	NULL
transactivator	NULL
mediates	NULL
its	NULL
effects	NULL
through	NULL
the	NULL
DQB	NULL
gene	NULL
X2	NULL
element	NULL
.	NULL

Ono	NULL
and	NULL
Song	NULL
(	NULL
17	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
reporter	NULL
constructs	NULL
bearing	NULL
the	NULL
DQB	NULL
promoter	NULL
are	NULL
active	NULL
in	NULL
clone	NULL
13	NULL
while	NULL
similar	NULL
DRA	NULL
promoter	NULL
constructs	NULL
are	NULL
not	NULL
.	NULL

Replacement	NULL
of	NULL
the	NULL
DR	NULL
A	NULL
X2	NULL
site	NULL
with	NULL
that	NULL
from	NULL
DQB	NULL
renders	NULL
it	NULL
transcriptionally	NULL
active	NULL
in	NULL
clone	NULL
13	NULL
.	NULL

Conversely	NULL
,	NULL
replacement	NULL
of	NULL
the	NULL
DQB	NULL
X2	NULL
box	NULL
with	NULL
that	NULL
from	NULL
DR	NULL
A	NULL
abolishes	NULL
transcription	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
X2	NULL
elements	NULL
of	NULL
DR	NULL
A	NULL
and	NULL
DQB	NULL
might	NULL
bind	NULL
different	NULL
factors	NULL
in	NULL
clone	NULL
13	NULL
.	NULL

Further	NULL
,	NULL
the	NULL
factor	NULL
in	NULL
clone	NULL
13	NULL
that	NULL
transactivates	NULL
DQ	NULL
is	NULL
not	NULL
present	NULL
in	NULL
other	NULL
CHT	NULL
A-deficient	NULL
cell	NULL
lines	NULL
.	NULL

Isotype-selective	NULL
binding	NULL
of	NULL
factors	NULL
to	NULL
class	NULL
II	NULL
promoters	NULL
has	NULL
been	NULL
demonstrated	NULL
previously	NULL
.	NULL

A	NULL
family	NULL
of	NULL
X1	NULL
box	NULL
binding	NULL
proteins	NULL
,	NULL
RFX	NULL
1-5	NULL
,	NULL
has	NULL
been	NULL
cloned	NULL
,	NULL
one	NULL
of	NULL
which	NULL
,	NULL
RFX	NULL
5	NULL
,	NULL
is	NULL
composed	NULL
of	NULL
two	NULL
subunits	NULL
and	NULL
comprises	NULL
the	NULL
nu-cleoprotein	NULL
complex	NULL
called	NULL
RFX	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
the	NULL
75-kD	NULL
subunit	NULL
of	NULL
RFX5	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
the	NULL
gene	NULL
defective	NULL
in	NULL
group	NULL
IV	NULL
MHC	NULL
class	NULL
II	NULL
CID	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
introduction	NULL
of	NULL
a	NULL
wild-type	NULL
RFX5	NULL
cDNA	NULL
into	NULL
group	NULL
IV	NULL
cells	NULL
not	NULL
only	NULL
restores	NULL
class	NULL
II	NULL
expression	NULL
but	NULL
also	NULL
results	NULL
in	NULL
the	NULL
reappearance	NULL
of	NULL
the	NULL
RFX	NULL
binding	NULL
complex	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
the	NULL
transfected	NULL
cells	NULL
Whereas	NULL
the	NULL
purified	NULL
RFX	NULL
complex	NULL
consisting	NULL
of	NULL
both	NULL
the	NULL
75-	NULL
and	NULL
36-kD	NULL
subunits	NULL
shows	NULL
moderate	NULL
binding	NULL
affinity	NULL
to	NULL
some	NULL
class	NULL
II	NULL
X1	NULL
boxes	NULL
(	NULL
DR	NULL
A	NULL
and	NULL
DPA	NULL
)	NULL
,	NULL
its	NULL
binding	NULL
to	NULL
others	NULL
is	NULL
very	NULL
weak	NULL
or	NULL
nonexistent	NULL
.	NULL

Cooperative	NULL
binding	NULL
between	NULL
NF-Y	NULL
,	NULL
a	NULL
het-erodimeric	NULL
complex	NULL
that	NULL
binds	NULL
all	NULL
class	NULL
II	NULL
promoter	NULL
Y	NULL
boxes	NULL
,	NULL
and	NULL
RFX	NULL
5	NULL
,	NULL
however	NULL
,	NULL
increases	NULL
the	NULL
stability	NULL
of	NULL
complex	NULL
formation	NULL
between	NULL
each	NULL
of	NULL
these	NULL
factors	NULL
and	NULL
its	NULL
binding	NULL
site	NULL
,	NULL
thus	NULL
increasing	NULL
the	NULL
apparent	NULL
affinity	NULL
of	NULL
RFX5	NULL
for	NULL
those	NULL
X1	NULL
boxes	NULL
that	NULL
it	NULL
can	NULL
not	NULL
bind	NULL
on	NULL
its	NULL
own	NULL
.	NULL

Several	NULL
isotype-selective	NULL
X2	NULL
box	NULL
binding	NULL
proteins	NULL
have	NULL
also	NULL
been	NULL
identified	NULL
either	NULL
by	NULL
molecular	NULL
cloning	NULL
or	NULL
by	NULL
biochemical	NULL
means	NULL
.	NULL

Among	NULL
these	NULL
are	NULL
hXBP-1	NULL
(	NULL
27	NULL
)	NULL
,	NULL
ATF-2	NULL
or	NULL
mxXBP	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
,	NULL
c-jun	NULL
(	NULL
30	NULL
)	NULL
,	NULL
and	NULL
X2BP	NULL
(	NULL
31	NULL
)	NULL
.	NULL

We	NULL
think	NULL
it	NULL
unlikely	NULL
that	NULL
any	NULL
of	NULL
these	NULL
factors	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
DQ	NULL
expression	NULL
in	NULL
clone	NULL
13	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
hXBP-1	NULL
,	NULL
a	NULL
basic	NULL
region	NULL
leucine-zipper	NULL
protein	NULL
,	NULL
binds	NULL
to	NULL
the	NULL
X2	NULL
site	NULL
in	NULL
the	NULL
DR	NULL
A	NULL
and	NULL
DPB	NULL
,	NULL
but	NULL
not	NULL
DQB	NULL
genes	NULL
.	NULL

Consistent	NULL
with	NULL
its	NULL
isotype-selective	NULL
binding	NULL
,	NULL
transfection	NULL
of	NULL
antisense	NULL
hXBP-1	NULL
into	NULL
the	NULL
class	NULL
II-positive	NULL
B-LCL	NULL
Raji	NULL
decreased	NULL
HLA-DR	NULL
and	NULL
-DP	NULL
but	NULL
not	NULL
HLA-DQ	NULL
expression	NULL
(	NULL
32	NULL
)	NULL
.	NULL

This	NULL
pattern	NULL
of	NULL
binding	NULL
and	NULL
transactivation	NULL
is	NULL
the	NULL
opposite	NULL
of	NULL
the	NULL
clone	NULL
13	NULL
1892	NULL
phenotype	NULL
.	NULL

ATF-2	NULL
(	NULL
mXBP	NULL
)	NULL
was	NULL
also	NULL
originally	NULL
isolated	NULL
by	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
X2	NULL
site	NULL
,	NULL
but	NULL
mice	NULL
bearing	NULL
a	NULL
germ-line	NULL
mutation	NULL
in	NULL
this	NULL
gene	NULL
have	NULL
normal	NULL
levels	NULL
of	NULL
class	NULL
II	NULL
,	NULL
suggesting	NULL
that	NULL
ATF-2	NULL
is	NULL
not	NULL
an	NULL
essential	NULL
element	NULL
of	NULL
the	NULL
class	NULL
II	NULL
transcription	NULL
machinery	NULL
(	NULL
33	NULL
)	NULL
.	NULL

X2BP	NULL
was	NULL
originally	NULL
identified	NULL
as	NULL
an	NULL
X2-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
Raji	NULL
cells	NULL
Unlike	NULL
other	NULL
X2	NULL
box	NULL
binding	NULL
complexes	NULL
,	NULL
it	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
X2	NULL
boxes	NULL
of	NULL
both	NULL
the	NULL
Â«	NULL
and	NULL
B	NULL
chain	NULL
genes	NULL
of	NULL
the	NULL
same	NULL
isotype	NULL
(	NULL
HLA-DR	NULL
)	NULL
,	NULL
but	NULL
,	NULL
like	NULL
the	NULL
others	NULL
,	NULL
individually	NULL
,	NULL
it	NULL
does	NULL
not	NULL
bind	NULL
well	NULL
to	NULL
the	NULL
X2	NULL
boxes	NULL
of	NULL
other	NULL
isotypes	NULL
such	NULL
as	NULL
DQ	NULL
A	NULL
,	NULL
DQB	NULL
,	NULL
or	NULL
DPA	NULL
.	NULL

X2BP	NULL
,	NULL
which	NULL
is	NULL
found	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
class	NULL
II-positive	NULL
B	NULL
cells	NULL
,	NULL
can	NULL
bind	NULL
cooperatively	NULL
to	NULL
the	NULL
X2	NULL
box	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
RFX	NULL
(	NULL
34	NULL
)	NULL
and	NULL
can	NULL
form	NULL
stable	NULL
higher	NULL
order	NULL
complexes	NULL
with	NULL
RFX	NULL
and	NULL
NF-Y	NULL
on	NULL
a	NULL
DRA	NULL
promoter	NULL
probe	NULL
in	NULL
EMSA	NULL
(	NULL
26	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
strongly	NULL
suggest	NULL
that	NULL
X2BP	NULL
is	NULL
a	NULL
functionally	NULL
important	NULL
X2	NULL
box	NULL
factor	NULL
.	NULL

Nev-ertheless	NULL
,	NULL
its	NULL
isotype	NULL
binding	NULL
profile	NULL
does	NULL
not	NULL
match	NULL
well	NULL
to	NULL
the	NULL
clone	NULL
13	NULL
phenotype	NULL
.	NULL

Neither	NULL
the	NULL
individual	NULL
binding	NULL
profiles	NULL
of	NULL
these	NULL
X2	NULL
box	NULL
binding	NULL
proteins	NULL
,	NULL
nor	NULL
their	NULL
ability	NULL
to	NULL
bind	NULL
all	NULL
class	NULL
II	NULL
promoters	NULL
in	NULL
a	NULL
higher	NULL
order	NULL
nucleo-pro-tein	NULL
complex	NULL
,	NULL
fits	NULL
the	NULL
phenotype	NULL
of	NULL
the	NULL
clone	NULL
13	NULL
HLA-DQ	NULL
transactivator	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
clone	NULL
13	NULL
DQ	NULL
trans	NULL
activator	NULL
protein	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
isolated	NULL
.	NULL

A	NULL
schematic	NULL
diagram	NULL
of	NULL
the	NULL
major	NULL
factors	NULL
relevant	NULL
to	NULL
class	NULL
II	NULL
transcription	NULL
and	NULL
the	NULL
as-acting	NULL
elements	NULL
through	NULL
which	NULL
they	NULL
are	NULL
thought	NULL
to	NULL
act	NULL
can	NULL
be	NULL
found	NULL
in	NULL
Mach	NULL
et	NULL
al	NULL
.	NULL

(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
the	NULL
clone	NULL
13	NULL
HLA-DQ	NULL
transactivator	NULL
to	NULL
function	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CHIT	NULL
A	NULL
is	NULL
intriguing	NULL
.	NULL

Though	NULL
apparently	NULL
not	NULL
a	NULL
DNA-binding	NULL
protein	NULL
itself	NULL
(	NULL
26	NULL
)	NULL
,	NULL
CHT	NULL
A	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
both	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
the	NULL
coordinate	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
in	NULL
both	NULL
constitutive	NULL
and	NULL
inducible	NULL
systems	NULL
.	NULL

Indeed	NULL
,	NULL
there	NULL
has	NULL
been	NULL
a	NULL
good	NULL
correlation	NULL
to	NULL
date	NULL
between	NULL
the	NULL
expression	NULL
of	NULL
CIITA	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
.	NULL

In	NULL
all	NULL
cell	NULL
lines	NULL
that	NULL
map	NULL
to	NULL
MHC	NULL
class	NULL
II	NULL
CID	NULL
complementation	NULL
group	NULL
II	NULL
,	NULL
the	NULL
introduction	NULL
of	NULL
a	NULL
wild-type	NULL
copy	NULL
of	NULL
CHT	NULL
A	NULL
causes	NULL
the	NULL
coordinate	NULL
reexpression	NULL
of	NULL
all	NULL
three	NULL
HLA	NULL
isotypes	NULL
(	NULL
13	NULL
,	NULL
16	NULL
)	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
that	NULL
CIT	NULL
A	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
by	NULL
IFN-y	NULL
in	NULL
cultured	NULL
fibroblasts	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
class	NULL
II	NULL
antigen	NULL
expression	NULL
in	NULL
plasmacytes	NULL
and	NULL
in	NULL
activated	NULL
murine	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
reversed	NULL
by	NULL
the	NULL
introduction	NULL
of	NULL
a	NULL
functional	NULL
copy	NULL
of	NULL
the	NULL
CHT	NULL
A	NULL
gene	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
.	NULL

However	NULL
,	NULL
there	NULL
are	NULL
two	NULL
examples	NULL
of	NULL
class	NULL
II	NULL
expression	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CHT	NULL
A	NULL
.	NULL

Class	NULL
II	NULL
is	NULL
expressed	NULL
on	NULL
rare	NULL
interdigitating	NULL
reticular	NULL
thymic	NULL
cells	NULL
in	NULL
CHT	NULL
A-defi-	NULL
An	NULL
HLA-DQ	NULL
specific	NULL
T	NULL
ransactivator	NULL
cient	NULL
mice	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
cell	NULL
line	NULL
R	NULL
J2.2.5	NULL
is	NULL
somewhat	NULL
leaky	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
HLA-DR	NULL
(	NULL
Douhan	NULL
III	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
LH	NULL
.	NULL

Glimcher	NULL
,	NULL
unpublished	NULL
observation	NULL
)	NULL
,	NULL
despite	NULL
the	NULL
lack	NULL
of	NULL
a	NULL
functional	NULL
CHT	NULL
A	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
CHT	NULL
A-independent	NULL
expression	NULL
of	NULL
HLA-DQ	NULL
in	NULL
clone	NULL
13	NULL
is	NULL
not	NULL
unprec-edented	NULL
.	NULL

What	NULL
type	NULL
of	NULL
mechanism	NULL
or	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
might	NULL
account	NULL
for	NULL
the	NULL
CHIT	NULL
A-independent	NULL
expression	NULL
of	NULL
HLA-DQ	NULL
in	NULL
clone	NULL
137	NULL
It	NULL
is	NULL
possible	NULL
that	NULL
a	NULL
DQ	NULL
-specific	NULL
factor	NULL
that	NULL
is	NULL
normally	NULL
regulated	NULL
by	NULL
CIT	NULL
A	NULL
has	NULL
lost	NULL
its	NULL
dependence	NULL
on	NULL
CIT	NULL
A	NULL
as	NULL
a	NULL
result	NULL
of	NULL
a	NULL
dominant-acting	NULL
mutation	NULL
.	NULL

Alternatively	NULL
,	NULL
a	NULL
factor	NULL
not	NULL
normally	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
CHTA	NULL
might	NULL
have	NULL
acquired	NULL
the	NULL
ability	NULL
to	NULL
do	NULL
so	NULL
as	NULL
the	NULL
result	NULL
of	NULL
a	NULL
mutation	NULL
.	NULL

Finally	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
clone	NULL
13	NULL
,	NULL
the	NULL
experimentally	NULL
derived	NULL
class	NULL
II-negative	NULL
cells	NULL
lines	NULL
in	NULL
group	NULL
II	NULL
were	NULL
generated	NULL
by	NULL
mutagenesis	NULL
followed	NULL
by	NULL
immunoselection	NULL
for	NULL
lack	NULL
of	NULL
class	NULL
II	NULL
expression	NULL
(	NULL
18	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Clone	NULL
13	NULL
,	NULL
however	NULL
,	NULL
was	NULL
derived	NULL
as	NULL
a	NULL
subclone	NULL
of	NULL
P3J-HR-1	NULL
cells	NULL
,	NULL
a	NULL
mutant	NULL
B	NULL
cell	NULL
line	NULL
in	NULL
turn	NULL
derived	NULL
from	NULL
Jijoye	NULL
,	NULL
a	NULL
class	NULL
II-positive	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
.	NULL

The	NULL
P3J-HR	NULL
-	NULL
1	NULL
cell	NULL
line	NULL
is	NULL
a	NULL
very	NULL
high	NULL
producer	NULL
of	NULL
viral	NULL
capsid	NULL
antigen	NULL
,	NULL
whereas	NULL
the	NULL
subclone	NULL
clone	NULL
13	NULL
was	NULL
identified	NULL
initially	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
produce	NULL
large	NULL
amounts	NULL
of	NULL
virus	NULL
in	NULL
response	NULL
to	NULL
treatment	NULL
with	NULL
TPA	NULL
(	NULL
41	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
expression	NULL
of	NULL
HLA-DQ	NULL
in	NULL
clone	NULL
13	NULL
is	NULL
related	NULL
to	NULL
the	NULL
transforming	NULL
EBV	NULL
present	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Although	NULL
transformation	NULL
of	NULL
human	NULL
B	NULL
lymphocytes	NULL
with	NULL
EBV	NULL
does	NULL
not	NULL
usu-	NULL
ally	NULL
alter	NULL
their	NULL
MHC	NULL
class	NULL
II	NULL
phenotype	NULL
(	NULL
B	NULL
lymphocytes	NULL
from	NULL
MHC	NULL
class	NULL
II-deficient	NULL
patients	NULL
remain	NULL
class	NULL
II-negative	NULL
after	NULL
transformation	NULL
)	NULL
,	NULL
it	NULL
is	NULL
known	NULL
that	NULL
EBV	NULL
transformation	NULL
often	NULL
causes	NULL
reexpression	NULL
of	NULL
class	NULL
I	NULL
antigens	NULL
in	NULL
B	NULL
cells	NULL
derived	NULL
from	NULL
BLS	NULL
type	NULL
I	NULL
patients	NULL
(	NULL
9	NULL
)	NULL
.	NULL

There	NULL
are	NULL
several	NULL
examples	NULL
of	NULL
cell	NULL
lines	NULL
,	NULL
both	NULL
normal	NULL
and	NULL
malignant	NULL
,	NULL
in	NULL
which	NULL
noncoordinate	NULL
expression	NULL
of	NULL
the	NULL
class	NULL
II	NULL
genes	NULL
has	NULL
been	NULL
observed	NULL
.	NULL

In	NULL
human	NULL
dermal	NULL
fibroblasts	NULL
,	NULL
treatment	NULL
with	NULL
IFN-y	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
HLA-DR	NULL
and	NULL
-DP	NULL
but	NULL
not	NULL
HLA-DQ	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Malignant	NULL
B	NULL
cells	NULL
have	NULL
been	NULL
described	NULL
that	NULL
fail	NULL
to	NULL
express	NULL
one	NULL
or	NULL
more	NULL
specific	NULL
class	NULL
II	NULL
isotypes	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
human	NULL
eosinophils	NULL
,	NULL
HLA-DR	NULL
but	NULL
not	NULL
HLA-DQ	NULL
is	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Whether	NULL
any	NULL
of	NULL
these	NULL
examples	NULL
of	NULL
noncoordinate	NULL
regulation	NULL
of	NULL
the	NULL
class	NULL
II	NULL
genes	NULL
involves	NULL
a	NULL
CIT	NULL
A-independent	NULL
pathway	NULL
like	NULL
that	NULL
in	NULL
clone	NULL
13	NULL
is	NULL
currently	NULL
un-known	NULL
.	NULL

Despite	NULL
the	NULL
highly	NULL
conserved	NULL
nature	NULL
of	NULL
the	NULL
class	NULL
II	NULL
proxi-mal	NULL
promoters	NULL
and	NULL
the	NULL
identification	NULL
of	NULL
factors	NULL
such	NULL
as	NULL
CITA	NULL
and	NULL
RFX5	NULL
,	NULL
which	NULL
are	NULL
known	NULL
to	NULL
influence	NULL
the	NULL
coordinate	NULL
expression	NULL
of	NULL
the	NULL
class	NULL
II	NULL
genes	NULL
,	NULL
it	NULL
is	NULL
becoming	NULL
increasingly	NULL
clear	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
expression	NULL
of	NULL
individual	NULL
class	NULL
II	NULL
genes	NULL
may	NULL
involve	NULL
gene-specific	NULL
as	NULL
elements	NULL
and	NULL
trans-acting	NULL
factors	NULL
,	NULL
which	NULL
in	NULL
some	NULL
cases	NULL
may	NULL
result	NULL
in	NULL
noncoordinate	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
S.	NULL
Saidman	NULL
,	NULL
Massachusetts	NULL
General	NULL
Hospital	NULL
,	NULL
for	NULL
determining	NULL
the	NULL
HLA-DQ	NULL
haplotypes	NULL
of	NULL
clone	NULL
13	NULL
and	NULL
Raji	NULL
,	NULL
and	NULL
Dr.	NULL
M.H	NULL
.	NULL

Kaplan	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

M.	NULL
Gavin	NULL
and	NULL
M.	NULL
Simone	NULL
provided	NULL
expert	NULL
assistance	NULL
with	NULL
flow	NULL
cytometry	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
grant	NULL
UO	NULL
1	NULL
A131541	NULL
(	NULL
LH	NULL
.	NULL

Glimcher	NULL
)	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Dr.	NULL
Laurie	NULL
H.	NULL
Glimcher	NULL
,	NULL
Harvard	NULL
School	NULL
of	NULL
Public	NULL
Health	NULL
,	NULL
Department	NULL
of	NULL
Cancer	NULL
Biology	NULL
,	NULL
665	NULL
Huntington	NULL
Avenue	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
,	NULL
02115	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
14	NULL
August	NULL
1996	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
3	NULL
Apnl	NULL
1997	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Schwartz	NULL
,	NULL
R.H.	NULL
1986	NULL
.	NULL

Immune	NULL
response	NULL
(	NULL
Ir	NULL
)	NULL
genes	NULL
of	NULL
the	NULL
murine	NULL
major	NULL
histocompatibility	NULL
complex	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

38	NULL
:	NULL
31-201	NULL
.	NULL

2	NULL
.	NULL

Glimcher	NULL
,	NULL
LH	NULL
.	NULL

,	NULL
and	NULL
C.J	NULL
.	NULL

Kara	NULL
.	NULL

1992	NULL
.	NULL

Sequences	NULL
and	NULL
factors	NULL
:	NULL
a	NULL
guide	NULL
to	NULL
MHC	NULL
class-II	NULL
transcription	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10	NULL
:	NULL
13-49	NULL
.	NULL

3	NULL
.	NULL

Paulnock-King	NULL
,	NULL
D.	NULL
,	NULL
K.C	NULL
.	NULL

Sizer	NULL
,	NULL
Y.R	NULL
.	NULL

Freund	NULL
,	NULL
P.P	NULL
.	NULL

Jones	NULL
,	NULL
and	NULL
JR.	NULL
Parnes	NULL
.	NULL

1985	NULL
.	NULL

Coordinate	NULL
induction	NULL
of	NULL
Ia	NULL
alpha	NULL
,	NULL
beta	NULL
,	NULL
and	NULL
Ii	NULL
mRNA	NULL
in	NULL
a	NULL
macrophage	NULL
cell	NULL
line	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

135	NULL
:	NULL
632-636	NULL
.	NULL

4.	NULL
de	NULL
Preval	NULL
,	NULL
C.	NULL
,	NULL
M.R	NULL
.	NULL

Hadam	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1988	NULL
.	NULL

Regulation	NULL
of	NULL
genes	NULL
for	NULL
HLA	NULL
class	NULL
II	NULL
antigens	NULL
in	NULL
cell	NULL
lines	NULL
from	NULL
patients	NULL
with	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J	NULL
Med	NULL
318:1295-1300	NULL
.	NULL

5	NULL
.	NULL

Benoist	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
D.	NULL
Mathis	NULL
.	NULL

1990	NULL
.	NULL

Regulation	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class-II	NULL
genes	NULL
:	NULL
X	NULL
,	NULL
Y	NULL
and	NULL
other	NULL
letters	NULL
1893	NULL
Douhan	NULL
et	NULL
al	NULL
.	NULL

of	NULL
the	NULL
alphabet	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8:68	NULL
1-715	NULL
.	NULL

6	NULL
.	NULL

Accolla	NULL
,	NULL
R.S	NULL
.	NULL

,	NULL
G.	NULL
Carra	NULL
,	NULL
and	NULL
J.	NULL
Guardiola	NULL
.	NULL

1985	NULL
.	NULL

Reactivation	NULL
by	NULL
a	NULL
trans-acting	NULL
factor	NULL
of	NULL
human	NULL
major	NULL
histocompatibility	NULL
complex	NULL
Ia	NULL
gene	NULL
expression	NULL
in	NULL
interspecies	NULL
hybrids	NULL
between	NULL
an	NULL
Ia-negative	NULL
human	NULL
B-cell	NULL
variant	NULL
and	NULL
an	NULL
Ia-positive	NULL
mouse	NULL
B-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

82:5145-5149	NULL
.	NULL

7	NULL
.	NULL

Yang	NULL
,	NULL
Z.	NULL
,	NULL
R.S	NULL
.	NULL

Accolla	NULL
,	NULL
D.	NULL
Pious	NULL
,	NULL
B.J	NULL
.	NULL

Zegers	NULL
,	NULL
and	NULL
JL	NULL
Strominger	NULL
.	NULL

1988	NULL
.	NULL

Two	NULL
distinct	NULL
genetic	NULL
loci	NULL
regulating	NULL
class	NULL
II	NULL
gene	NULL
expression	NULL
are	NULL
defective	NULL
in	NULL
human	NULL
mutant	NULL
and	NULL
patient	NULL
cell	NULL
lines	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

7:1965-1972	NULL
.	NULL

8	NULL
.	NULL

Hume	NULL
,	NULL
CR	NULL
.	NULL

,	NULL
and	NULL
J.S	NULL
.	NULL

Lee	NULL
.	NULL

1989	NULL
.	NULL

Congenital	NULL
immunodefi-ciencies	NULL
associated	NULL
with	NULL
absence	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
antigens	NULL
on	NULL
lymphocytes	NULL
result	NULL
from	NULL
distinct	NULL
mutations	NULL
in	NULL
trans-acting	NULL
factors	NULL
.	NULL

Hum	NULL
.	NULL

Immunol	NULL
.	NULL

26:288-309	NULL
.	NULL

9	NULL
.	NULL

Benichou	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Strominger	NULL
.	NULL

1991	NULL
.	NULL

Class	NULL
H-antigen-negative	NULL
patient	NULL
and	NULL
mutant	NULL
B-cell	NULL
lines	NULL
represent	NULL
at	NULL
least	NULL
three	NULL
,	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23.	NULL
and	NULL
probably	NULL
four	NULL
,	NULL
distinct	NULL
genetic	NULL
defects	NULL
defined	NULL
by	NULL
complementation	NULL
analysis	NULL
Proc	NULL
Natl	NULL
.	NULL

Aad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

88:4285-4288	NULL
.	NULL

Peijnenburg	NULL
,	NULL
A.	NULL
,	NULL
B.	NULL
Godthelp	NULL
,	NULL
A.	NULL
van	NULL
Boxel-Dezaire	NULL
,	NULL
and	NULL
P.J	NULL
.	NULL

van	NULL
den	NULL
Elsen	NULL
.	NULL

1995	NULL
.	NULL

Definition	NULL
of	NULL
a	NULL
novel	NULL
complementation	NULL
group	NULL
in	NULL
MHC	NULL
class	NULL
II	NULL
deficiency	NULL
.	NULL

Immunogenetics	NULL
.	NULL

41:287-294	NULL
.	NULL

Douhan	NULL
,	NULL
J.	NULL
,	NULL
JA	NULL
.	NULL

Brown	NULL
,	NULL
Z.L	NULL
.	NULL

Gleit	NULL
,	NULL
C.S	NULL
.	NULL

David	NULL
,	NULL
and	NULL
LH	NULL
.	NULL

Glimcher	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
E-beta	NULL
gene	NULL
in	NULL
vivo	NULL
:	NULL
lessons	NULL
from	NULL
E	NULL
(	NULL
beta	NULL
)	NULL
(	NULL
D	NULL
)	NULL
transgenic	NULL
mice	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

8:255-265	NULL
.	NULL

Mach	NULL
,	NULL
B.	NULL
,	NULL
V.	NULL
Steimle	NULL
,	NULL
E.	NULL
Martinez-Soria	NULL
,	NULL
and	NULL
W.	NULL
Reith	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
:	NULL
lessons	NULL
from	NULL
a	NULL
dis	NULL
ease	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:301-331	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
L.A.	NULL
Otten	NULL
,	NULL
M.	NULL
Zufferey	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1993	NULL
.	NULL

Complementation	NULL
cloning	NULL
of	NULL
an	NULL
MHC	NULL
class	NULL
II	NULL
transactivator	NULL
mutated	NULL
in	NULL
hereditary	NULL
MHC	NULL
class	NULL
II	NULL
deficiency	NULL
(	NULL
or	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
)	NULL
.	NULL

Cell	NULL
.	NULL

75:135-146	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
B.	NULL
Durand	NULL
,	NULL
E.	NULL
Barras	NULL
M.	NULL
Zufferey	NULL
,	NULL
MR.	NULL
Hadam	NULL
,	NULL
B.	NULL
Mach	NULL
,	NULL
and	NULL
W.	NULL
Reith	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
novel	NULL
DNA-binding	NULL
regulatory	NULL
factor	NULL
is	NULL
mutated	NULL
in	NULL
primary	NULL
MHC	NULL
class	NULL
II	NULL
deficiency	NULL
(	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:1021-1032	NULL
.	NULL

Ono	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
V.	NULL
Bazil	NULL
,	NULL
M.	NULL
Sugawara	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Strominger	NULL
.	NULL

1991	NULL
.	NULL

An	NULL
isotype-specific	NULL
trans-acting	NULL
factor	NULL
is	NULL
defective	NULL
in	NULL
a	NULL
mutant	NULL
B	NULL
cell	NULL
line	NULL
that	NULL
expresses	NULL
HLA-DQ	NULL
,	NULL
but	NULL
not	NULL
-DR	NULL
or	NULL
-DP	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173:629-637	NULL
.	NULL

Zhou	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
LH	NULL
.	NULL

Glimcher	NULL
.	NULL

1995	NULL
.	NULL

Human	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
directed	NULL
by	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
CHIT	NULL
A	NULL
,	NULL
one	NULL
of	NULL
the	NULL
defective	NULL
genes	NULL
in	NULL
type	NULL
II	NULL
MHC	NULL
combined	NULL
immune	NULL
deficiency	NULL
.	NULL

Immunity	NULL
.	NULL

2:545-553	NULL
.	NULL

Ono	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
and	NULL
Z	NULL
.	NULL

Song	NULL
.	NULL

1995	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
interaction	NULL
site	NULL
of	NULL
the	NULL
defective	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
mutant	NULL
cell	NULL
line	NULL
clone-13	NULL
to	NULL
the	NULL
divergent	NULL
X2-box	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:6396-6402	NULL
.	NULL

Accolla	NULL
,	NULL
R.S	NULL
.	NULL

1983	NULL
.	NULL

Human	NULL
B	NULL
cell	NULL
variants	NULL
immunoselected	NULL
against	NULL
a	NULL
single	NULL
Ta	NULL
antigen	NULL
subset	NULL
have	NULL
lost	NULL
expression	NULL
of	NULL
several	NULL
Ta	NULL
antigen	NULL
subsets	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

157:1053-1058	NULL
.	NULL

Zhou	NULL
,	NULL
H.	NULL
,	NULL
H.S	NULL
.	NULL

Su	NULL
,	NULL
X.	NULL
Zhang	NULL
,	NULL
J.	NULL
Douhan	NULL
III	NULL
,	NULL
and	NULL
LH	NULL
.	NULL

Glimcher	NULL
.	NULL

1997	NULL
.	NULL

CIT	NULL
A-dependent	NULL
and	NULL
independent	NULL
class	NULL
II	NULL
MHC	NULL
expression	NULL
revealed	NULL
by	NULL
a	NULL
dominant	NULL
negative	NULL
mutant	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

In	NULL
press	NULL
.	NULL

Dignam	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
R.M	NULL
.	NULL

Lebovitz	NULL
,	NULL
and	NULL
R.G	NULL
.	NULL

Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RN	NULL
A	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nudeic	NULL
A	NULL
ads	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

Seabright	NULL
,	NULL
M.	NULL
1971	NULL
.	NULL

A	NULL
rapid	NULL
banding	NULL
technique	NULL
for	NULL
human	NULL
chromosomes	NULL
.	NULL

Lanett	NULL
.	NULL

2:971-972	NULL
.	NULL

Knoll	NULL
,	NULL
JH.M	NULL
.	NULL

,	NULL
and	NULL
P.	NULL
Lichter	NULL
.	NULL

1994	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
to	NULL
metaphase	NULL
chromosomes	NULL
and	NULL
interphase	NULL
nuclei	NULL
.	NULL

In	NULL
Current	NULL
protocols	NULL
in	NULL
human	NULL
genetics	NULL
.	NULL

Vol	NULL
.	NULL

1	NULL
.	NULL

N.C.	NULL
Dracopoli	NULL
,	NULL
JL	NULL
.	NULL

Haines	NULL
,	NULL
B.R	NULL
.	NULL

Korf	NULL
,	NULL
D.T	NULL
.	NULL

Moir	NULL
,	NULL
C.C	NULL
.	NULL

Morton	NULL
,	NULL
C.E	NULL
.	NULL

Seidman	NULL
and	NULL
J.G	NULL
.	NULL

Seidman	NULL
,	NULL
editors	NULL
.	NULL

Green-Wiley	NULL
,	NULL
New	NULL
York	NULL
.	NULL

4.3.1-4.3.28	NULL
.	NULL

Chirgwin	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
A.E	NULL
.	NULL

Przybyla	NULL
,	NULL
R.J.	NULL
MacDonald	NULL
,	NULL
and	NULL
WJ	NULL
.	NULL

R	NULL
utter	NULL
.	NULL

1979	NULL
.	NULL

Isolation	NULL
of	NULL
biologically	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
enriched	NULL
in	NULL
ribonuclease	NULL
.	NULL

Biochemistry	NULL
.	NULL

18:5294-5299	NULL
.	NULL

23a	NULL
.	NULL

Nomura	NULL
,	NULL
N.	NULL
,	NULL
M.	NULL
Ota	NULL
,	NULL
K.	NULL
Tsuji	NULL
,	NULL
and	NULL
H.	NULL
Inoko	NULL
.	NULL

1991	NULL
.	NULL

HLA	NULL
24	NULL
.	NULL

25	NULL
.	NULL

DQBI	NULL
genotyping	NULL
by	NULL
a	NULL
modified	NULL
PCR-RFLP	NULL
method	NULL
combined	NULL
with	NULL
group-specific	NULL
primers	NULL
.	NULL

Tissue	NULL
Antigens	NULL
.	NULL

38:53-59	NULL
.	NULL

Riley	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
S.D	NULL
.	NULL

Westerheide	NULL
,	NULL
J.A	NULL
.	NULL

Price	NULL
,	NULL
J.A	NULL
.	NULL

Brown	NULL
,	NULL
and	NULL
J.M	NULL
.	NULL

Boss	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
class	NULL
II	NULL
MHC	NULL
genes	NULL
requires	NULL
both	NULL
the	NULL
X	NULL
box	NULL
region	NULL
and	NULL
the	NULL
class	NULL
II	NULL
transactivator	NULL
(	NULL
CHIT	NULL
A	NULL
)	NULL
.	NULL

Immunity	NULL
.	NULL

2:533-543	NULL
.	NULL

Brown	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
X.F	NULL
.	NULL

He	NULL
,	NULL
SD	NULL
.	NULL

Westerheide	NULL
,	NULL
and	NULL
J.M	NULL
.	NULL

Boss	NULL
.	NULL

1894	NULL
26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

1996	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
expressed	NULL
CIITA	NULL
allele	NULL
in	NULL
the	NULL
class	NULL
II	NULL
MHC	NULL
transcriptional	NULL
mutant	NULL
R	NULL
J2.2.5	NULL
.	NULL

Immunogenetics	NULL
.	NULL

43:88-91	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
,	NULL
V.	NULL
Steimle	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1995	NULL
.	NULL

Molecular	NULL
defects	NULL
in	NULL
the	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
and	NULL
regulation	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

16:539-546	NULL
.	NULL

Liou	NULL
,	NULL
H.C.	NULL
,	NULL
M.R	NULL
.	NULL

Boothby	NULL
,	NULL
P.W	NULL
.	NULL

Finn	NULL
,	NULL
R	NULL
.	NULL

Davidon	NULL
,	NULL
N.	NULL
Na-bavi	NULL
,	NULL
N.J.	NULL
Zeleznik-Le	NULL
,	NULL
J.P.	NULL
Ting	NULL
,	NULL
and	NULL
LH	NULL
.	NULL

Glimcher	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
new	NULL
member	NULL
of	NULL
the	NULL
leucine	NULL
zipper	NULL
class	NULL
of	NULL
proteins	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
HLA	NULL
DR	NULL
alpha	NULL
promoter	NULL
.	NULL

Scere	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

247:1581-1584	NULL
.	NULL

Liou	NULL
,	NULL
H.C.	NULL
,	NULL
M.R	NULL
.	NULL

Boothby	NULL
,	NULL
and	NULL
LH	NULL
.	NULL

Glimcher	NULL
.	NULL

1988	NULL
.	NULL

Distinct	NULL
cloned	NULL
class	NULL
II	NULL
MHC	NULL
DNA	NULL
binding	NULL
proteins	NULL
recognize	NULL
the	NULL
X	NULL
box	NULL
transcription	NULL
element	NULL
.	NULL

Sdene	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

242	NULL
:	NULL
69-71	NULL
.	NULL

Ivashkiv	NULL
,	NULL
LB	NULL
.	NULL

,	NULL
H.C.	NULL
Liou	NULL
,	NULL
C.J	NULL
.	NULL

Kara	NULL
,	NULL
W.W.	NULL
Lamph	NULL
,	NULL
LM	NULL
.	NULL

Verma	NULL
,	NULL
and	NULL
LH	NULL
.	NULL

Glimcher	NULL
.	NULL

1990.	NULL
mXBP/CRE-BP2	NULL
and	NULL
c-Jun	NULL
form	NULL
a	NULL
complex	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
cyclic	NULL
AMP	NULL
,	NULL
but	NULL
not	NULL
to	NULL
the	NULL
12-O	NULL
-tetradecanoylphorbol-13-acetate	NULL
,	NULL
response	NULL
element	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:1609-1621	NULL
.	NULL

Andersson	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
B.M	NULL
.	NULL

Peterlin	NULL
.	NULL

1990	NULL
.	NULL

NF-X2	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
DRA	NULL
X2-box	NULL
is	NULL
activator	NULL
protein	NULL
1	NULL
.	NULL

Expression	NULL
cloning	NULL
of	NULL
c-Jun	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

145:3456-3462	NULL
.	NULL

Hasegawa	NULL
,	NULL
S.L	NULL
.	NULL

,	NULL
and	NULL
J.M	NULL
.	NULL

Boss	NULL
.	NULL

1991	NULL
.	NULL

Two	NULL
B	NULL
cell	NULL
factors	NULL
bind	NULL
the	NULL
HLA-DR	NULL
A	NULL
X	NULL
box	NULL
region	NULL
and	NULL
recognize	NULL
different	NULL
subsets	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
promoters	NULL
.	NULL

NudeicA	NULL
ads	NULL
Res	NULL
.	NULL

19:6269-6276	NULL
.	NULL

Ono	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
H.C.	NULL
Liou	NULL
,	NULL
R	NULL
.	NULL

Davidon	NULL
,	NULL
J.L	NULL
.	NULL

Strominger	NULL
,	NULL
and	NULL
LH	NULL
.	NULL

Glimcher	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
X-box-binding	NULL
protein	NULL
1	NULL
is	NULL
required	NULL
for	NULL
the	NULL
transcription	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
human	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
genes	NULL
and	NULL
forms	NULL
a	NULL
heterodimer	NULL
with	NULL
c-fos	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

8	NULL
$	NULL
8:4309-4312	NULL
.	NULL

Reimold	NULL
,	NULL
A.M.	NULL
,	NULL
M.J.	NULL
Grusby	NULL
,	NULL
B.	NULL
Kosaras	NULL
,	NULL
J.W	NULL
.	NULL

Fries	NULL
,	NULL
R.	NULL
Mori	NULL
,	NULL
S.	NULL
Maniwa	NULL
,	NULL
LM	NULL
.	NULL

Clauss	NULL
,	NULL
T.	NULL
Collins	NULL
,	NULL
R	NULL
.L	NULL
.	NULL

Sidman	NULL
,	NULL
M.J.	NULL
Glimcher	NULL
,	NULL
and	NULL
LH	NULL
.	NULL

Glimcher	NULL
.	NULL

1996	NULL
.	NULL

Chondrodysplasia	NULL
and	NULL
neurological	NULL
abnormalities	NULL
in	NULL
ATF-2-deficient	NULL
mice	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

379:262-265	NULL
.	NULL

Moreno	NULL
,	NULL
C.S	NULL
.	NULL

,	NULL
P.	NULL
Emery	NULL
,	NULL
J.E	NULL
.	NULL

West	NULL
,	NULL
B.	NULL
Durand	NULL
,	NULL
W.	NULL
Reith	NULL
,	NULL
B.	NULL
Mach	NULL
,	NULL
and	NULL
J.M	NULL
.	NULL

Boss	NULL
1995	NULL
.	NULL

Purified	NULL
X2	NULL
binding	NULL
protein	NULL
(	NULL
X2BP	NULL
)	NULL
cooperatively	NULL
binds	NULL
the	NULL
class	NULL
II	NULL
MHC	NULL
X	NULL
box	NULL
region	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
purified	NULL
RFX	NULL
,	NULL
the	NULL
X	NULL
box	NULL
factor	NULL
deficient	NULL
in	NULL
the	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

155:4313-4321	NULL
.	NULL

Chang	NULL
,	NULL
C.H	NULL
.	NULL

,	NULL
J.D	NULL
.	NULL

Fontes	NULL
,	NULL
M.	NULL
Peterlin	NULL
,	NULL
and	NULL
R.A.	NULL
Flavell	NULL
.	NULL

1994	NULL
.	NULL

Class	NULL
II	NULL
transactivator	NULL
(	NULL
CHIT	NULL
A	NULL
)	NULL
is	NULL
sufficient	NULL
for	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:1367-1374	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
C.A	NULL
.	NULL

Siegrist	NULL
,	NULL
A.	NULL
Mottet	NULL
,	NULL
B.	NULL
Lisowska-Grospi-erre	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
expression	NULL
by	NULL
interferon-gamma	NULL
mediated	NULL
by	NULL
the	NULL
transactivator	NULL
gene	NULL
CIITA	NULL
.	NULL

Sdene	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

265:106-109	NULL
.	NULL

Silacci	NULL
,	NULL
P.	NULL
,	NULL
A.	NULL
Mottet	NULL
,	NULL
V.	NULL
Steimle	NULL
,	NULL
W.	NULL
Reith	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1994	NULL
.	NULL

Developmental	NULL
extinction	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
gene	NULL
expression	NULL
in	NULL
plasmocytes	NULL
is	NULL
mediated	NULL
by	NULL
silencing	NULL
of	NULL
the	NULL
transactivator	NULL
gene	NULL
CIITA	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:1329-1336	NULL
.	NULL

Chang	NULL
,	NULL
C.H	NULL
.	NULL

,	NULL
S.C.	NULL
Hong	NULL
,	NULL
C.C	NULL
.	NULL

Hughes	NULL
,	NULL
C.J	NULL
.	NULL

Janeway	NULL
,	NULL
and	NULL
R.A.	NULL
Flavell	NULL
.	NULL

1995	NULL
.	NULL

CIITA	NULL
activates	NULL
the	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
in	NULL
mouse	NULL
T	NULL
cells	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

7:1515-1518	NULL
.	NULL

Chang	NULL
,	NULL
C.H	NULL
.	NULL

,	NULL
S.	NULL
Guerder	NULL
,	NULL
S.C.	NULL
Hong	NULL
,	NULL
W.	NULL
van	NULL
Ewijk	NULL
,	NULL
and	NULL
R.A.	NULL
Flavell	NULL
.	NULL

1996	NULL
.	NULL

Mice	NULL
lacking	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
transactivator	NULL
(	NULL
CIITA	NULL
)	NULL
show	NULL
tissue-specific	NULL
impairment	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
expression	NULL
.	NULL

Immunity	NULL
.	NULL

4:167-178	NULL
.	NULL

Calman	NULL
,	NULL
A.F	NULL
.	NULL

,	NULL
and	NULL
B.M	NULL
.	NULL

Peterlin	NULL
.	NULL

1987	NULL
.	NULL

Mutant	NULL
human	NULL
B	NULL
cell	NULL
lines	NULL
deficient	NULL
in	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
An	NULL
HLA-DQ	NULL
specific	NULL
T	NULL
ransactivator	NULL
41	NULL
.	NULL

42	NULL
.	NULL

43.	NULL
transcription	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

139:2489-2495	NULL
.	NULL

Heston	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
Rabson	NULL
,	NULL
N.	NULL
Brown	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1982	NULL
.	NULL

New	NULL
Epstein-Barr	NULL
virus	NULL
variants	NULL
from	NULL
cellular	NULL
subclones	NULL
of	NULL
P3J-HR	NULL
-	NULL
1	NULL
Burkitt	NULL
lymphoma	NULL
.	NULL

Natwre	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

295:160-163	NULL
.	NULL

Blanck	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Lok	NULL
,	NULL
K.	NULL
Kok	NULL
,	NULL
E.	NULL
Downie	NULL
,	NULL
J.H	NULL
.	NULL

Korn	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Strominger	NULL
.	NULL

1990	NULL
.	NULL

Gamma-interferon	NULL
induction	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
mRNAs	NULL
in	NULL
dermal	NULL
fibroblasts	NULL
studied	NULL
by	NULL
RNAse	NULL
protection	NULL
analysis	NULL
.	NULL

Hum	NULL
.	NULL

Immunol	NULL
.	NULL

29:150-156	NULL
.	NULL

Pesando	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
and	NULL
L.	NULL
Graf	NULL
.	NULL

1986	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
1895	NULL
Douhan	NULL
et	NULL
al	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

HLA-DR	NULL
,	NULL
-DQ	NULL
,	NULL
and	NULL
-DP	NULL
antigens	NULL
on	NULL
malignant	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

136:4311-4318	NULL
.	NULL

Pesando	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
L.	NULL
Graf	NULL
,	NULL
and	NULL
P.	NULL
Hoffman	NULL
.	NULL

1986	NULL
.	NULL

HLA-DP	NULL
can	NULL
be	NULL
expressed	NULL
with	NULL
or	NULL
without	NULL
-DR	NULL
molecules	NULL
on	NULL
a	NULL
malignant	NULL
B	NULL
cell	NULL
line	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

137:1932-1936	NULL
.	NULL

Lucey	NULL
,	NULL
D.R	NULL
.	NULL

,	NULL
A.	NULL
Nicholson-Weller	NULL
,	NULL
and	NULL
P.F	NULL
.	NULL

Weller	NULL
.	NULL

1989	NULL
.	NULL

Mature	NULL
human	NULL
eosinophils	NULL
have	NULL
the	NULL
capacity	NULL
to	NULL
express	NULL
HLA-DR	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

86:1348-1351	NULL
.	NULL

